{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T02:13:59Z","timestamp":1790043239886,"version":"4.0.1"},"publisher-location":"Cham","reference-count":198,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783032121653","type":"print"},{"value":"9783032121660","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-3-032-12166-0_9","type":"book-chapter","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T11:17:35Z","timestamp":1783768655000},"page":"245-269","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Epigenetics and One-Carbon Metabolism in Cancer: Mechanisms and Therapeutic Implications"],"prefix":"10.1007","author":[{"given":"Jacinta","family":"Serpa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana R.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,12]]},"reference":[{"issue":"1","key":"9_CR1","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1182\/blood-2009-03-210039","volume":"114","author":"O Abdel-Wahab","year":"2009","unstructured":"Abdel-Wahab O, Mullally A, Hedvat C, Garcia-Manero G, Patel J, Wadleigh M, Malinge S, Yao J, Kilpivaara O, Bhat R, Huberman K, Thomas S, Dolgalev I, Heguy A, Paietta E, Le Beau MM, Beran M, Tallman MS, Ebert BL et al (2009) Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies. Blood 114(1):144\u2013147. https:\/\/doi.org\/10.1182\/blood-2009-03-210039","journal-title":"Blood"},{"issue":"1","key":"9_CR2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13148-021-01057-x","volume":"13","author":"S Amatori","year":"2021","unstructured":"Amatori S, Tavolaro S, Gambardella S, Fanelli M (2021) The dark side of histones: genomic organization and role of oncohistones in cancer. Clin Epigenetics 13(1):71. https:\/\/doi.org\/10.1186\/s13148-021-01057-x","journal-title":"Clin Epigenetics"},{"issue":"4","key":"9_CR3","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.tibs.2014.02.004","volume":"39","author":"I Amelio","year":"2014","unstructured":"Amelio I, Cutruzzol\u00e1 F, Antonov A, Agostini M, Melino G (2014) Serine and glycine metabolism in cancer. Trends Biochem Sci 39(4):191\u2013198. https:\/\/doi.org\/10.1016\/j.tibs.2014.02.004","journal-title":"Trends Biochem Sci"},{"issue":"1","key":"9_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10071","volume":"6","author":"J An","year":"2015","unstructured":"An J, Gonz\u00e1lez-Avalos E, Chawla A, Jeong M, L\u00f3pez-Moyado IF, Li W, Goodell MA, Chavez L, Ko M, Rao A (2015) Acute loss of TET function results in aggressive myeloid cancer in mice. Nat Commun 6(1):10071. https:\/\/doi.org\/10.1038\/ncomms10071","journal-title":"Nat Commun"},{"issue":"19","key":"9_CR5","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1182\/blood.2020010081","volume":"138","author":"GP Andrieu","year":"2021","unstructured":"Andrieu GP, Kohn M, Simonin M, Smith CL, Cieslak A, Dourthe M-\u00c9, Charbonnier G, Graux C, Huguet F, Lh\u00e9ritier V, Dombret H, Spicuglia S, Rousselot P, Boissel N, Asnafi V (2021) PRC2 loss of function confers a targetable vulnerability to BET proteins in T-ALL. Blood 138(19):1855\u20131869. https:\/\/doi.org\/10.1182\/blood.2020010081","journal-title":"Blood"},{"issue":"2","key":"9_CR6","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1158\/1541-7786.MCR-16-0317","volume":"15","author":"Z Ashkavand","year":"2017","unstructured":"Ashkavand Z, O\u2019Flanagan C, Hennig M, Du X, Hursting SD, Krupenko SA (2017) Metabolic reprogramming by folate restriction leads to a less aggressive cancer phenotype. Mol Cancer Res 15(2):189\u2013200. https:\/\/doi.org\/10.1158\/1541-7786.MCR-16-0317","journal-title":"Mol Cancer Res"},{"issue":"5","key":"9_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/gm346","volume":"4","author":"D Balasubramanian","year":"2012","unstructured":"Balasubramanian D, Akhtar-Zaidi B, Song L, Bartels CF, Veigl M, Beard L, Myeroff L, Guda K, Lutterbaugh J, Willis J, Crawford GE, Markowitz SD, Scacheri PC (2012) H3K4me3 inversely correlates with DNA methylation at a large class of non-CpG-island-containing start sites. Genome Med 4(5):47. https:\/\/doi.org\/10.1186\/gm346","journal-title":"Genome Med"},{"key":"9_CR8","doi-asserted-by":"publisher","unstructured":"Bandaru N, Noor SM, Kammili ML, Bonthu MG, Gayatri AP, Kumar PK (2025) Methionine restriction for cancer therapy: from preclinical studies to clinical trials. Cancer Pathog Ther (In press). https:\/\/doi.org\/10.1016\/J.CPT.2025.01.002","DOI":"10.1016\/J.CPT.2025.01.002"},{"issue":"2","key":"9_CR9","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.cell.2013.03.011","volume":"153","author":"T Baubec","year":"2013","unstructured":"Baubec T, Iv\u00e1nek R, Lienert F, Sch\u00fcbeler D (2013) Methylation-dependent and -independent genomic targeting principles of the MBD protein family. Cell\u2002153(2):480\u2013492.\u2002https:\/\/doi.org\/10.1016\/j.cell.2013.03.011","journal-title":"Cell"},{"issue":"1","key":"9_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/EPIGENOMES9010005","volume":"9","author":"AA Baumann","year":"2025","unstructured":"Baumann AA, Buribayev Z, Wolkenhauer O, Salybekov AA, Wolfien M (2025) Epigenomic echoes\u2014decoding genomic and epigenetic instability to distinguish lung cancer types and predict relapse. Epigenomes 9(1):5. https:\/\/doi.org\/10.3390\/EPIGENOMES9010005","journal-title":"Epigenomes"},{"issue":"3","key":"9_CR11","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.3390\/IJMS24032346","volume":"24","author":"RA Bekdash","year":"2023","unstructured":"Bekdash RA (2023) Methyl donors, epigenetic alterations, and brain health: understanding the connection. Int J Mol Sci 24(3):2346. https:\/\/doi.org\/10.3390\/IJMS24032346","journal-title":"Int J Mol Sci"},{"issue":"5","key":"9_CR12","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.ccr.2013.10.006","volume":"24","author":"S Bender","year":"2013","unstructured":"Bender S, Tang Y, Lindroth AM, Hovestadt V, Jones DTW, Kool M, Zapatka M, Northcott PA, Sturm D, Wang W, Radlwimmer B, H\u00f8jfeldt JW, Truffaux N, Castel D, Schubert S, Ryzhova M, \u015eeker-Cin H, Gronych J, Johann PD, Pfister SM (2013) Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas. Cancer Cell 24(5):660\u2013672. https:\/\/doi.org\/10.1016\/j.ccr.2013.10.006","journal-title":"Cancer Cell"},{"issue":"1","key":"9_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/srep37393","volume":"6","author":"SH Bernhart","year":"2016","unstructured":"Bernhart SH, Kretzmer H, Holdt LM, J\u00fchling F, Ammerpohl O, Bergmann AK, Northoff BH, Doose G, Siebert R, Stadler PF, Hoffmann S (2016) Changes of bivalent chromatin coincide with increased expression of developmental genes in cancer. Sci Rep 6(1):37393. https:\/\/doi.org\/10.1038\/srep37393","journal-title":"Sci Rep"},{"issue":"1","key":"9_CR14","doi-asserted-by":"publisher","first-page":"6874","DOI":"10.1038\/s41598-023-33932-3","volume":"13","author":"N Besselink","year":"2023","unstructured":"Besselink N, Keijer J, Vermeulen C, Boymans S, de Ridder J, van Hoeck A, Cuppen E, Kuijk E (2023) The genome-wide mutational consequences of DNA hypomethylation. Sci Rep 13(1):6874. https:\/\/doi.org\/10.1038\/s41598-023-33932-3","journal-title":"Sci Rep"},{"issue":"3","key":"9_CR15","doi-asserted-by":"publisher","first-page":"580","DOI":"10.3390\/CANCERS12030580","volume":"12","author":"E Bia\u0142opiotrowicz","year":"2020","unstructured":"Bia\u0142opiotrowicz E, Noyszewska-Kania M, Kachamakova-Trojanowska N, \u0141oboda A, Cybulska M, Grochowska A, Kopczy\u0144ski M, Mikula M, Prochorec-Sobieszek M, Firczuk M, Graczyk-Jarzynka A, Zago\u017cd\u017con R, Z\u0105bek A, M\u0142ynarz P, Dulak J, G\u00f3rniak P, Szyd\u0142owski M, Pyziak K, Martyka J et al (2020) Serine biosynthesis pathway supports MYC\u2013miR-494\u2013EZH2 feed-forward circuit necessary to maintain metabolic and epigenetic reprogramming of burkitt lymphoma cells. Cancers 12(3):580. https:\/\/doi.org\/10.3390\/CANCERS12030580","journal-title":"Cancers"},{"issue":"4","key":"9_CR16","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1093\/ADVANCES\/NMAA028","volume":"11","author":"P Bin","year":"2020","unstructured":"Bin P, Zhu C, Liu S, Li Z, Ren W, Zhu G (2020) Perspective: methionine restriction\u2013induced longevity \u2014 a possible role for inhibiting the synthesis of bacterial quorum sensing molecules. Adv Nutr 11(4):773\u2013783. https:\/\/doi.org\/10.1093\/ADVANCES\/NMAA028","journal-title":"Adv Nutr"},{"issue":"1","key":"9_CR17","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1101\/gad.947102","volume":"16","author":"A Bird","year":"2002","unstructured":"Bird A (2002) DNA methylation patterns and epigenetic memory. Genes Dev 16(1):6\u201321. https:\/\/doi.org\/10.1101\/gad.947102","journal-title":"Genes Dev"},{"issue":"1","key":"9_CR18","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/0092-8674(85)90312-5","volume":"40","author":"A Bird","year":"1985","unstructured":"Bird A, Taggart M, Frommer M, Miller OJ, Macleod D (1985) A fraction of the mouse genome that is derived from islands of nonmethylated, CpG-rich DNA. Cell 40(1):91\u201399. https:\/\/doi.org\/10.1016\/0092-8674(85)90312-5","journal-title":"Cell"},{"issue":"5","key":"9_CR19","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1080\/17474086.2018.1453802","volume":"11","author":"SR Bohl","year":"2018","unstructured":"Bohl SR, Bullinger L, R\u00fccker FG (2018) Epigenetic therapy: azacytidine and decitabine in acute myeloid leukemia. Expert Rev Hematol 11(5):361\u2013371. https:\/\/doi.org\/10.1080\/17474086.2018.1453802","journal-title":"Expert Rev Hematol"},{"issue":"5","key":"9_CR20","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3390\/METABO12050373","volume":"12","author":"AC Bravo","year":"2022","unstructured":"Bravo AC, Aguilera MNL, Marziali NR, Moritz L, Wingert V, Klotz K, Schumann A, Gr\u00fcnert SC, Spiekerkoetter U, Berger U, Lederer AK, Huber R, Hannibal L (2022) Analysis of S-adenosylmethionine and S-adenosylhomocysteine: method optimisation and profiling in healthy adults upon short-term dietary intervention. Metabolites 12(5):373. https:\/\/doi.org\/10.3390\/METABO12050373","journal-title":"Metabolites"},{"issue":"16","key":"9_CR21","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1182\/blood.2019000015","volume":"134","author":"M Broux","year":"2019","unstructured":"Broux M, Prieto C, Demeyer S, Vanden Bempt M, Alberti-Servera L, Lodewijckx I, Vandepoel R, Mentens N, Gielen O, Jacobs K, Geerdens E, Vicente C, de Bock CE, Cools J (2019) Suz12 inactivation cooperates with JAK3 mutant signaling in the development of T-cell acute lymphoblastic leukemia. Blood 134(16):1323\u20131336. https:\/\/doi.org\/10.1182\/blood.2019000015","journal-title":"Blood"},{"issue":"8","key":"9_CR22","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.trecan.2021.06.004","volume":"7","author":"A Buqu\u00e9","year":"2021","unstructured":"Buqu\u00e9 A, Galluzzi L, Montrose DC (2021) Targeting serine in cancer: is two better than one? Trends Cancer\u20027(8):668\u2013670.\u2002https:\/\/doi.org\/10.1016\/j.trecan.2021.06.004","journal-title":"Trends Cancer"},{"issue":"6","key":"9_CR23","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.tem.2021.03.003","volume":"32","author":"M Butler","year":"2021","unstructured":"Butler M, van der Meer LT, van Leeuwen FN (2021) Amino acid depletion therapies: starving cancer cells to death. Trends Endocrinol Metabol 32(6):367\u2013381. https:\/\/doi.org\/10.1016\/j.tem.2021.03.003","journal-title":"Trends Endocrinol Metabol"},{"issue":"2","key":"9_CR24","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/PATH.4659","volume":"238","author":"RN Carter","year":"2016","unstructured":"Carter RN, Morton NM (2016) Cysteine and hydrogen sulphide in the regulation of metabolism: Insights from genetics and pharmacology. J Pathol 238(2):321\u2013332. https:\/\/doi.org\/10.1002\/PATH.4659","journal-title":"J Pathol"},{"issue":"6","key":"9_CR25","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.ctrv.2012.01.004","volume":"38","author":"P Cavuoto","year":"2012","unstructured":"Cavuoto P, Fenech MF (2012) A review of methionine dependency and the role of methionine restriction in cancer growth control and life-span extension. Cancer Treat Rev 38(6):726\u2013736. https:\/\/doi.org\/10.1016\/j.ctrv.2012.01.004","journal-title":"Cancer Treat Rev"},{"issue":"11","key":"9_CR26","doi-asserted-by":"publisher","first-page":"3349","DOI":"10.7150\/jca.38391","volume":"11","author":"R Chen","year":"2020","unstructured":"Chen R, Zhao W-Q, Fang C, Yang X, Ji M (2020) Histone methyltransferase SETD2: a potential tumor suppressor in solid cancers. J Cancer 11(11):3349\u20133356. https:\/\/doi.org\/10.7150\/jca.38391","journal-title":"J Cancer"},{"issue":"5","key":"9_CR27","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.ccell.2016.09.006","volume":"30","author":"W-L Chen","year":"2016","unstructured":"Chen W-L, Wang Y-Y, Zhao A, Xia L, Xie G, Su M, Zhao L, Liu J, Qu C, Wei R, Rajani C, Ni Y, Cheng Z, Chen Z, Chen S-J, Jia W (2016) Enhanced fructose utilization mediated by SLC2A5 is a unique metabolic feature of acute myeloid leukemia with therapeutic potential. Cancer Cell 30(5):779\u2013791. https:\/\/doi.org\/10.1016\/j.ccell.2016.09.006","journal-title":"Cancer Cell"},{"issue":"1","key":"9_CR28","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/S41392-024-02030-9","volume":"9","author":"Y Chen","year":"2024","unstructured":"Chen Y, Liang R, Li Y, Jiang L, Ma D, Luo Q, Song G (2024) Chromatin accessibility: biological functions, molecular mechanisms and therapeutic application. Sig Transduct Target Ther 9(1):340. https:\/\/doi.org\/10.1038\/S41392-024-02030-9","journal-title":"Sig Transduct Target Ther"},{"key":"9_CR29","doi-asserted-by":"publisher","first-page":"873030","DOI":"10.3389\/FPHAR.2022.873030","volume":"13","author":"Z Chen","year":"2022","unstructured":"Chen Z, Hu Y, Jin L, Yang F, Ding H, Zhang L, Li L, Pan T (2022) The emerging role of N6-methyladenosine RNA methylation as regulators in cancer therapy and drug resistance. Front Pharmacol 13:873030. https:\/\/doi.org\/10.3389\/FPHAR.2022.873030","journal-title":"Front Pharmacol"},{"issue":"7","key":"9_CR30","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrc2876","volume":"10","author":"P Chi","year":"2010","unstructured":"Chi P, Allis CD, Wang GG (2010) Covalent histone modifications \u2014 miswritten, misinterpreted and mis-erased in human cancers. Nat Rev Cancer 10(7):457\u2013469. https:\/\/doi.org\/10.1038\/nrc2876","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"9_CR31","doi-asserted-by":"publisher","first-page":"5382","DOI":"10.3390\/IJMS22105382","volume":"22","author":"PY Chu","year":"2021","unstructured":"Chu PY, Wu HJ, Wang SM, Chen PM, Tang FY, Chiang EPI (2021) Mat2a localization and its independently prognostic relevance in breast cancer patients. Int J Mol Sci 22(10):5382. https:\/\/doi.org\/10.3390\/IJMS22105382","journal-title":"Int J Mol Sci"},{"issue":"6","key":"9_CR32","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/ni.3148","volume":"16","author":"L Cimmino","year":"2015","unstructured":"Cimmino L, Dawlaty MM, Ndiaye-Lobry D, Yap YS, Bakogianni S, Yu Y, Bhattacharyya S, Shaknovich R, Geng H, Lobry C, Mullenders J, King B, Trimarchi T, Aranda-Orgilles B, Liu C, Shen S, Verma AK, Jaenisch R, Aifantis I (2015) TET1 is a tumor suppressor of hematopoietic malignancy. Nat Immunol 16(6):653\u2013662. https:\/\/doi.org\/10.1038\/ni.3148","journal-title":"Nat Immunol"},{"issue":"6","key":"9_CR33","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.cell.2017.07.032","volume":"170","author":"L Cimmino","year":"2017","unstructured":"Cimmino L, Dolgalev I, Wang Y, Yoshimi A, Martin GH, Wang J, Ng V, Xia B, Witkowski MT, Mitchell-Flack M, Grillo I, Bakogianni S, Ndiaye-Lobry D, Mart\u00edn MT, Guillamot M, Banh RS, Xu M, Figueroa ME, Dickins RA (In press) (2017) Restoration of TET2 function blocks aberrant self-renewal and leukemia progression. Cell 170(6):1079\u20131095.e20. https:\/\/doi.org\/10.1016\/j.cell.2017.07.032","journal-title":"Cell"},{"issue":"8","key":"9_CR34","doi-asserted-by":"publisher","first-page":"114552","DOI":"10.1016\/j.celrep.2024.114552","volume":"43","author":"KO Conger","year":"2024","unstructured":"Conger KO, Chidley C, Ozgurses ME, Zhao H, Kim Y, Semina SE, Burns P, Rawat V, Lietuvninkas L, Sheldon R, Ben-Sahra I, Frasor J, Sorger PK, DeNicola GM, Coloff JL (2024) ASCT2 is a major contributor to serine uptake in cancer cells. Cell Rep 43(8):114552. https:\/\/doi.org\/10.1016\/j.celrep.2024.114552","journal-title":"Cell Rep"},{"key":"9_CR35","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1756-8722-7-30","volume":"7","author":"L Dai","year":"2014","unstructured":"Dai L, Cao Y, Chen Y, Parsons C, Qin Z (2014) Targeting xCT, a cystine-glutamate transporter induces apoptosis and tumor regression for KSHV\/HIV-associated lymphoma. J Hematol Oncol 7:30. https:\/\/doi.org\/10.1186\/1756-8722-7-30","journal-title":"J Hematol Oncol"},{"issue":"7","key":"9_CR36","first-page":"2020","volume":"10","author":"N Darwiche","year":"1978","unstructured":"Darwiche N (2020) Epigenetic mechanisms and the hallmarks of cancer: an intimate affair. Am J Cancer Res 10(7):1978. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7407342\/","journal-title":"Am J Cancer Res"},{"issue":"8","key":"9_CR37","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1158\/2159-8290.CD-23-0225","volume":"13","author":"A Davies","year":"2023","unstructured":"Davies A, Zoubeidi A, Beltran H, Selth LA (2023) The transcriptional and epigenetic landscape of cancer cell lineage plasticity. Cancer Discov 13(8):1771\u20131788. https:\/\/doi.org\/10.1158\/2159-8290.CD-23-0225","journal-title":"Cancer Discov"},{"issue":"5","key":"9_CR38","doi-asserted-by":"publisher","first-page":"e64420","DOI":"10.1371\/journal.pone.0064420","volume":"8","author":"CRT de Souza","year":"2013","unstructured":"de Souza CRT, Leal MF, Calcagno DQ, Costa Sozinho EK, Borges BdoN, Montenegro RC, dos Santos \u00c2KCR, dos Santos SEB, Ribeiro HF, Assump\u00e7\u00e3o PP, de Arruda Cardoso Smith M, Burbano RR (2013) MYC deregulation in gastric cancer and its clinicopathological implications. PLoS One 8(5):e64420. https:\/\/doi.org\/10.1371\/journal.pone.0064420","journal-title":"PLoS One"},{"issue":"3","key":"9_CR39","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/J.CMET.2011.08.004","volume":"14","author":"RJ Deberardinis","year":"2011","unstructured":"Deberardinis RJ (2011) Serine metabolism: some tumors take the road less traveled. Cell Metab 14(3):285. https:\/\/doi.org\/10.1016\/J.CMET.2011.08.004","journal-title":"Cell Metab"},{"issue":"6735","key":"9_CR40","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/20974","volume":"399","author":"C Dhalluin","year":"1999","unstructured":"Dhalluin C, Carlson JE, Zeng L, He C, Aggarwal AK, Zhou M-M (1999) Structure and ligand of a histone acetyltransferase bromodomain. Nature 399(6735):491\u2013496. https:\/\/doi.org\/10.1038\/20974","journal-title":"Nature"},{"issue":"22","key":"9_CR41","doi-asserted-by":"publisher","first-page":"4315","DOI":"10.1182\/blood.V128.22.4315.4315","volume":"128","author":"N Dighe","year":"2016","unstructured":"Dighe N, Venkatesan S, Zhiyong P, Hwang WY (2016) Mechanism of action of azacytidine in myelodysplastic syndromes (MDS). Blood 128(22):4315. https:\/\/doi.org\/10.1182\/blood.V128.22.4315.4315","journal-title":"Blood"},{"issue":"6","key":"9_CR42","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.2217\/epi.15.39","volume":"7","author":"Q Du","year":"2015","unstructured":"Du Q, Luu P-L, Stirzaker C, Clark SJ (2015) Methyl-CpG-binding domain proteins: readers of the epigenome. Epigenomics 7(6):1051\u20131073. https:\/\/doi.org\/10.2217\/epi.15.39","journal-title":"Epigenomics"},{"issue":"8 SUPPL.","key":"9_CR43","doi-asserted-by":"publisher","first-page":"2444S","DOI":"10.1093\/jn\/132.8.2444s","volume":"132","author":"SJ Duthie","year":"2002","unstructured":"Duthie SJ, Narayanan S, Brand GM, Pirie L, Grant G (2002) Impact of folate deficiency on DNA stability. J Nutr 132(8 Suppl.):2444S\u20132449S. https:\/\/doi.org\/10.1093\/jn\/132.8.2444s","journal-title":"J Nutr"},{"issue":"7","key":"9_CR44","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.3390\/ijms18071414","volume":"18","author":"T Eckschlager","year":"2017","unstructured":"Eckschlager T, Plch J, Stiborova M, Hrabeta J (2017) Histone deacetylase inhibitors as anticancer drugs. Int J Mol Sci 18(7):1414. https:\/\/doi.org\/10.3390\/ijms18071414","journal-title":"Int J Mol Sci"},{"issue":"5618","key":"9_CR45","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1126\/science.1083557","volume":"300","author":"A Eden","year":"2003","unstructured":"Eden A, Gaudet F, Waghmare A, Jaenisch R (2003) Chromosomal instability and tumors promoted by DNA\u2002hypomethylation.\u2002Science\u2002300(5618):455. https:\/\/doi.org\/10.1126\/science.1083557","journal-title":"Science"},{"issue":"5","key":"9_CR46","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1158\/0008-5472.CAN-22-1002","volume":"83","author":"A El-Kenawi","year":"2023","unstructured":"El-Kenawi A, Berglund A, Estrella V, Zhang Y, Liu M, Putney RM, Yoder SJ, Johnson J, Brown J, Gatenby R (2023) Elevated methionine flux drives pyroptosis evasion in persister cancer cells. Cancer Res 83(5):720\u2013734.\u2002https:\/\/doi.org\/10.1158\/0008-5472.CAN-22-1002","journal-title":"Cancer Res"},{"issue":"35","key":"9_CR47","doi-asserted-by":"publisher","first-page":"5427","DOI":"10.1038\/sj.onc.1205600","volume":"21","author":"M Esteller","year":"2002","unstructured":"Esteller M (2002) CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene 21(35):5427\u20135440. https:\/\/doi.org\/10.1038\/sj.onc.1205600","journal-title":"Oncogene"},{"issue":"8","key":"9_CR48","first-page":"3225","volume":"61","author":"M Esteller","year":"2001","unstructured":"Esteller M, Corn PG, Baylin SB, Herman JG (2001) A gene hypermethylation profile of human cancer. Cancer Res 61(8):3225\u20133229","journal-title":"Cancer Res"},{"issue":"36","key":"9_CR49","doi-asserted-by":"publisher","first-page":"13464","DOI":"10.1074\/jbc.RA119.008743","volume":"294","author":"TWM Fan","year":"2019","unstructured":"Fan TWM, Bruntz RC, Yang Y, Song H, Chernyavskaya Y, Deng P, Zhang Y, Shah PP, Beverly LJ, Qi Z, Mahan AL, Higashi RM, Dang CV, Lane AN (2019) De novo synthesis of serine and glycine fuels purine nucleotide biosynthesis in human lung cancer tissues. J Biol Chem 294(36):13464\u201313477. https:\/\/doi.org\/10.1074\/jbc.RA119.008743","journal-title":"J Biol Chem"},{"issue":"6291","key":"9_CR50","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1126\/science.aae0065","volume":"352","author":"D Fang","year":"2016","unstructured":"Fang D, Gan H, Lee J-H, Han J, Wang Z, Riester SM, Jin L, Chen J, Zhou H, Wang J, Zhang H, Yang N, Bradley EW, Ho TH, Rubin BP, Bridge JA, Thibodeau SN, Ordog T, Chen Yet al (2016) The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas. Science 352(6291):1344\u20131348. https:\/\/doi.org\/10.1126\/science.aae0065","journal-title":"Science"},{"issue":"5895","key":"9_CR51","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/301089a0","volume":"301","author":"AP Feinberg","year":"1983","unstructured":"Feinberg AP, Vogelstein B (1983) Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 301(5895):89\u201392. https:\/\/doi.org\/10.1038\/301089a0","journal-title":"Nature"},{"issue":"3","key":"9_CR52","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3390\/CANCERS17030535","volume":"17","author":"D Fern\u00e1ndez-Ramos","year":"2025","unstructured":"Fern\u00e1ndez-Ramos D, Lopitz-Otsoa F, Lu SC, Mato JM (2025) S-adenosylmethionine: a multifaceted regulator in cancer pathogenesis and therapy. Cancers 17(3):535. https:\/\/doi.org\/10.3390\/CANCERS17030535","journal-title":"Cancers"},{"issue":"6","key":"9_CR53","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.3390\/NU11061368","volume":"11","author":"A Ferrari","year":"2019","unstructured":"Ferrari A, Tardin Torrezan G, Maria Carraro D, Aguiar Junior S (2019) Association of folate and vitamins involved in the 1-carbon cycle with polymorphisms in the methylenetetrahydrofolate reductase gene (MTHFR) and global DNA methylation in patients with colorectal cancer. Nutrients 11(6):1368. https:\/\/doi.org\/10.3390\/NU11061368","journal-title":"Nutrients"},{"issue":"4","key":"9_CR54","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/ng1531","volume":"37","author":"MF Fraga","year":"2005","unstructured":"Fraga MF, Ballestar E, Villar-Garea A, Boix-Chornet M, Espada J, Schotta G, Bonaldi T, Haydon C, Ropero S, Petrie K, Iyer NG, P\u00e9rez-Rosado A, Calvo E, Lopez JA, Cano A, Calasanz MJ, Colomer D, Piris M\u00c1, Ahn N et al (2005) Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat Genet 37(4):391\u2013400. https:\/\/doi.org\/10.1038\/ng1531","journal-title":"Nat Genet"},{"issue":"4","key":"9_CR55","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.jhep.2013.04.031","volume":"59","author":"M Frau","year":"2013","unstructured":"Frau M, Feo F, Pascale RM (2013) Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis. J Hepatol 59(4):830\u2013841. https:\/\/doi.org\/10.1016\/j.jhep.2013.04.031","journal-title":"J Hepatol"},{"issue":"1","key":"9_CR56","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/S42003-022-03280-5","volume":"5","author":"K Fukumoto","year":"2022","unstructured":"Fukumoto K, Ito K, Saer B, Taylor G, Ye S, Yamano M, Toriba Y, Hayes A, Okamura H, Fustin JM (2022) Excess S-adenosylmethionine inhibits methylation via catabolism to adenine. Commun Biol 5(1):313. https:\/\/doi.org\/10.1038\/S42003-022-03280-5","journal-title":"Commun Biol"},{"issue":"12","key":"9_CR57","doi-asserted-by":"publisher","first-page":"111359","DOI":"10.1016\/J.ISCI.2024.111359","volume":"27","author":"Y Gao","year":"2024","unstructured":"Gao Y, Siyu Z, Zhang X, Du Y, Ni T, Hao S (2024) Crosstalk between metabolic and epigenetic modifications during cell carcinogenesis. IScience 27(12):111359. https:\/\/doi.org\/10.1016\/J.ISCI.2024.111359","journal-title":"IScience"},{"issue":"1","key":"9_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-33889-3","volume":"13","author":"MC Garrett","year":"2023","unstructured":"Garrett MC, Albano R, Carnwath T, Elahi L, Behrmann CA, Pemberton M, Woo D, O\u2019Brien E, VanCauwenbergh B, Perentesis J, Shah S, Hagan M, Kendler A, Zhao C, Paranjpe A, Roskin K, Kornblum H, Plas DR, Lu QR (2023) HDAC1 and HDAC6 are essential for driving growth in IDH1 mutant glioma. Sci Rep 13(1):12433. https:\/\/doi.org\/10.1038\/s41598-023-33889-3","journal-title":"Sci Rep"},{"key":"9_CR59","doi-asserted-by":"publisher","first-page":"175883592312205","DOI":"10.1177\/17588359231220511","volume":"16","author":"F Geissler","year":"2024","unstructured":"Geissler F, Nesic K, Kondrashova O, Dobrovic A, Swisher EM, Scott CL, J. Wakefield M (2024) The role of aberrant DNA methylation in cancer initiation and clinical impacts. Ther Adv Med Oncol 16:17588359231220512. https:\/\/doi.org\/10.1177\/17588359231220511","journal-title":"Ther Adv Med Oncol"},{"issue":"4","key":"9_CR60","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.ccell.2019.08.006","volume":"36","author":"AP Gomes","year":"2019","unstructured":"Gomes AP, Ilter D, Low V, Rosenzweig A, Shen Z-J, Schild T, Rivas MA, Er EE, McNally DR, Mutvei AP, Han J, Ou Y-H, Cavaliere P, Mullarky E, Nagiec M, Shin S, Yoon S-O, Dephoure N, Massagu\u00e9 J et al (2019) Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization. Cancer Cell 36(4):402\u2013417.e13. https:\/\/doi.org\/10.1016\/j.ccell.2019.08.006","journal-title":"Cancer Cell"},{"issue":"11","key":"9_CR61","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/S1470-2045(20)30451-4","volume":"21","author":"M Gounder","year":"2020","unstructured":"Gounder M, Sch\u00f6ffski P, Jones RL, Agulnik M, Cote GM, Villalobos VM, Attia S, Chugh R, Chen TW-W, Jahan T, Loggers ET, Gupta A, Italiano A, Demetri GD, Ratan R, Davis LE, Mir O, Dileo P, Van Tine BA et al (2020) Tazemetostat in advanced epithelioid sarcoma with loss of INI1\/SMARCB1: an international, open-label, phase 2 basket study. Lancet Oncol 21(11):1423\u20131432. https:\/\/doi.org\/10.1016\/S1470-2045(20)30451-4","journal-title":"Lancet Oncol"},{"issue":"51","key":"9_CR62","doi-asserted-by":"publisher","first-page":"eabc5629","DOI":"10.1126\/SCIADV.ABC5629","volume":"6","author":"CM Greco","year":"2020","unstructured":"Greco CM, Cervantes M, Fustin JM, Ito K, Ceglia N, Samad M, Shi J, Koronowski KB, Forne I, Ranjit S, Gaucher J, Kinouchi K, Kojima R, Gratton E, Li W, Baldi P, Imhof A, Okamura H, Sassone-Corsi P (2020) S-adenosyl-l-homocysteine hydrolase links methionine metabolism to the circadian clock and chromatin remodeling. Sci Adv 6(51):eabc5629. https:\/\/doi.org\/10.1126\/SCIADV.ABC5629","journal-title":"Sci Adv"},{"issue":"34","key":"9_CR63","doi-asserted-by":"publisher","first-page":"6211","DOI":"10.1038\/S41388-019-0869-4","volume":"38","author":"NH Green","year":"2019","unstructured":"Green NH, Galvan DL, Badal SS, Chang BH, LeBleu VS, Long J, Jonasch E, Danesh FR (2019) MTHFD2 links RNA methylation to metabolic reprogramming in renal cell carcinoma. Oncogene 38(34):6211\u20136225. https:\/\/doi.org\/10.1038\/S41388-019-0869-4","journal-title":"Oncogene"},{"issue":"4","key":"9_CR64","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/S0092-8674(00)80521-8","volume":"90","author":"W Gu","year":"1997","unstructured":"Gu W, Roeder RG (1997) Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90(4):595\u2013606. https:\/\/doi.org\/10.1016\/S0092-8674(00)80521-8","journal-title":"Cell"},{"issue":"13","key":"9_CR65","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1016\/j.cell.2023.05.028","volume":"186","author":"H Guo","year":"2023","unstructured":"Guo H, Vuille JA, Wittner BS, Lachtara EM, Hou Y, Lin M, Zhao T, Raman AT, Russell HC, Reeves BA, Pleskow HM, Wu C-L, Gnirke A, Meissner A, Efstathiou JA, Lee RJ, Toner M, Aryee MJ, Lawrence MS et al (2023) DNA hypomethylation silences anti-tumor immune genes in early prostate cancer and CTCs. Cell 186(13):2765\u20132782.e28. https:\/\/doi.org\/10.1016\/j.cell.2023.05.028","journal-title":"Cell"},{"issue":"5","key":"9_CR66","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1097\/CCO.0000000000000870","volume":"34","author":"J Guo","year":"2022","unstructured":"Guo J, Yang Y, Buettner R, Rosen ST (2022) Targeting the methionine-MAT2A-SAM axis for cancer therapy. Curr Opin Oncol 34(5):551. https:\/\/doi.org\/10.1097\/CCO.0000000000000870","journal-title":"Curr Opin Oncol"},{"key":"9_CR67","doi-asserted-by":"publisher","first-page":"114036","DOI":"10.1016\/j.biopha.2022.114036","volume":"157","author":"S Guo","year":"2023","unstructured":"Guo S, Zhu X, Huang Z, Wei C, Yu J, Zhang L, Feng J, Li M, Li Z (2023) Genomic instability drives tumorigenesis and metastasis and its implications for cancer therapy. Biomed Pharmacother 157:114036. https:\/\/doi.org\/10.1016\/j.biopha.2022.114036","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"9_CR68","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/J.CANLET.2011.07.024","volume":"312","author":"W Guo","year":"2011","unstructured":"Guo W, Zhao Y, Zhang Z, Tan N, Zhao F, Ge C, Liang L, Jia D, Chen T, Yao M, Li J, He X (2011) Disruption of xCT inhibits cell growth via the ROS\/autophagy pathway in hepatocellular carcinoma. Cancer Lett 312(1):55\u201361. https:\/\/doi.org\/10.1016\/J.CANLET.2011.07.024","journal-title":"Cancer Lett"},{"key":"9_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/SREP15029","volume":"5","author":"N Gustafsson Sheppard","year":"2015","unstructured":"Gustafsson Sheppard N, Jarl L, Mahadessian D, Strittmatter L, Schmidt A, Madhusudan N, Tegn\u00e9r J, Lundberg EK, Asplund A, Jain M, Nilsson R (2015) The folate-coupled enzyme MTHFD2 is a nuclear protein and promotes cell proliferation. Sci Rep 5: 15029. https:\/\/doi.org\/10.1038\/SREP15029","journal-title":"Sci Rep"},{"issue":"7184","key":"9_CR70","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nature06781","volume":"452","author":"H-J Han","year":"2008","unstructured":"Han H-J, Russo J, Kohwi Y, Kohwi-Shigematsu T (2008) SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis. Nature 452(7184):187\u2013193. https:\/\/doi.org\/10.1038\/nature06781","journal-title":"Nature"},{"issue":"1","key":"9_CR71","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D (2022) Hallmarks of cancer: new dimensions. Cancer Discov 12(1):31\u201346. https:\/\/doi.org\/10.1158\/2159-8290.CD-21-1059","journal-title":"Cancer Discov"},{"issue":"2","key":"9_CR72","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.molcel.2020.03.004","volume":"78","author":"SA Haws","year":"2020","unstructured":"Haws SA, Yu D, Ye C, Wille CK, Nguyen LC, Krautkramer KA, Tomasiewicz JL, Yang SE, Miller BR, Liu WH, Igarashi K, Sridharan R, Tu BP, Cryns VL, Lamming DW, Denu JM (2020) Methyl-metabolite depletion elicits adaptive responses to support heterochromatin stability and epigenetic persistence. Mol Cell 78(2):210\u2013223.e8. https:\/\/doi.org\/10.1016\/j.molcel.2020.03.004","journal-title":"Mol Cell"},{"issue":"12","key":"9_CR73","doi-asserted-by":"publisher","first-page":"3990","DOI":"10.1158\/1078-0432.CCR-09-0055","volume":"15","author":"DMEI Hellebrekers","year":"2009","unstructured":"Hellebrekers DMEI, Lentjes MHFM, van den Bosch SM, Melotte V, Wouters KAD, Daenen KLJ, Smits KM, Akiyama Y, Yuasa Y, Sanduleanu S, Khalid-de Bakker CAJ, Jonkers D, Weijenberg MP, Louwagie J, van Criekinge W, Carvalho B, Meijer GA, Baylin SB, Herman JG et al (2009) GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer. Clin Cancer Res 15(12):3990\u20133997. https:\/\/doi.org\/10.1158\/1078-0432.CCR-09-0055","journal-title":"Clin Cancer Res"},{"issue":"11","key":"9_CR74","doi-asserted-by":"publisher","first-page":"6538","DOI":"10.1128\/MCB.18.11.6538","volume":"18","author":"B Hendrich","year":"1998","unstructured":"Hendrich B, Bird A (1998) Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol Cell Biol 18(11):6538\u20136547. https:\/\/doi.org\/10.1128\/MCB.18.11.6538","journal-title":"Mol Cell Biol"},{"issue":"1","key":"9_CR75","doi-asserted-by":"publisher","DOI":"10.1186\/S12885-016-2367-1","volume":"16","author":"JR Hens","year":"2016","unstructured":"Hens JR, Sinha I, Perodin F, Cooper T, Sinha R, Plummer J, Perrone CE, Orentreich D (2016) Methionine-restricted diet inhibits growth of MCF10AT1-derived mammary tumors by increasing cell cycle inhibitors in athymic nude mice. BMC Cancer 16(1):349. https:\/\/doi.org\/10.1186\/S12885-016-2367-1","journal-title":"BMC Cancer"},{"issue":"2","key":"9_CR76","doi-asserted-by":"publisher","first-page":"166983","DOI":"10.1016\/j.bbadis.2023.166983","volume":"1870","author":"A Hip\u00f3lito","year":"2024","unstructured":"Hip\u00f3lito A, Xavier R, Brito C, Tom\u00e1s A, Lemos I, Caba\u00e7o LC, Silva F, Oliva A, Barral DC, Vicente JB, Gon\u00e7alves LG, Pojo M, Serpa J (2024) BRD9 status is a major contributor for cysteine metabolic remodeling through MST and EAAT3 modulation in malignant melanoma. Biochim Biophys Acta Mol Basis Dis 1870(2):166983. https:\/\/doi.org\/10.1016\/j.bbadis.2023.166983","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"8","key":"9_CR77","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/s41556-023-01191-z","volume":"25","author":"MS Hoetker","year":"2023","unstructured":"Hoetker MS, Yagi M, Di Stefano B, Langerman J, Cristea S, Wong LP, Huebner AJ, Charlton J, Deng W, Haggerty C, Sadreyev RI, Meissner A, Michor F, Plath K, Hochedlinger K (2023) H3K36 methylation maintains cell identity by regulating opposing lineage programmes. Nat Cell Biol 25(8):1121\u20131134. https:\/\/doi.org\/10.1038\/s41556-023-01191-z","journal-title":"Nat Cell Biol"},{"issue":"29","key":"9_CR78","doi-asserted-by":"publisher","first-page":"11994","DOI":"10.1073\/pnas.1310656110","volume":"110","author":"H Huang","year":"2013","unstructured":"Huang H, Jiang X, Li Z, Li Y, Song C-X, He C, Sun M, Chen P, Gurbuxani S, Wang J, Hong G-M, Elkahloun AG, Arnovitz S, Wang J, Szulwach K, Lin L, Street C, Wunderlich M, Dawlaty M et al (2013) TET1 plays an essential oncogenic role in MLL -rearranged leukemia. Proc Natl Acad Sci 110(29):11994\u201311999. https:\/\/doi.org\/10.1073\/pnas.1310656110","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"9_CR79","doi-asserted-by":"publisher","first-page":"e324","DOI":"10.1038\/EMM.2017.11","volume":"49","author":"K Hyun","year":"2017","unstructured":"Hyun K, Jeon J, Park K, Kim J (2017) Writing, erasing and reading histone lysine methylations. Exp Mol Med 49(4):e324. https:\/\/doi.org\/10.1038\/EMM.2017.11","journal-title":"Exp Mol Med"},{"issue":"2","key":"9_CR80","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/ng.298","volume":"41","author":"RA Irizarry","year":"2009","unstructured":"Irizarry RA, Ladd-Acosta C, Wen B, Wu Z, Montano C, Onyango P, Cui H, Gabo K, Rongione M, Webster M, Ji H, Potash JB, Sabunciyan S, Feinberg AP (2009) The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet 41(2):178\u2013186. https:\/\/doi.org\/10.1038\/ng.298","journal-title":"Nat Genet"},{"issue":"8","key":"9_CR81","doi-asserted-by":"publisher","first-page":"4226","DOI":"10.1093\/NAR\/GKZ111","volume":"47","author":"K Ishiguro","year":"2019","unstructured":"Ishiguro K, Arai T, Suzuki T (2019) Depletion of S-adenosylmethionine impacts on ribosome biogenesis through hypomodification of a single rRNA methylation. Nucleic Acids Res 47(8):4226\u20134239. https:\/\/doi.org\/10.1093\/NAR\/GKZ111","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"9_CR82","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.2967\/jnumed.114.142927","volume":"55","author":"M Iwamoto","year":"2014","unstructured":"Iwamoto M, Kawada K, Nakamoto Y, Itatani Y, Inamoto S, Toda K, Kimura H, Sasazuki T, Shirasawa S, Okuyama H, Inoue M, Hasegawa S, Togashi K, Sakai Y (2014) Regulation of 18F-FDG accumulation in colorectal cancer cells with mutated KRAS. J Nucl Med 55(12):2038\u20132044. https:\/\/doi.org\/10.2967\/jnumed.114.142927","journal-title":"J Nucl Med"},{"key":"9_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/S41418-024-01259-9","volume":"32","author":"A Janic","year":"2024","unstructured":"Janic A, Abad E, Amelio I (2024) Decoding p53 tumor suppression: a crosstalk between genomic stability and epigenetic control? Cell Death Differ 32:1\u20138. https:\/\/doi.org\/10.1038\/S41418-024-01259-9","journal-title":"Cell Death Differ"},{"issue":"36","key":"9_CR84","doi-asserted-by":"publisher","first-page":"5007","DOI":"10.1038\/S41388-018-0307-Z","volume":"37","author":"X Ji","year":"2018","unstructured":"Ji X, Qian J, Rahman SMJ, Siska PJ, Zou Y, Harris BK, Hoeksema MD, Trenary IA, Heidi C, Eisenberg R, Rathmell JC, Young JD, Massion PP (2018) xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression. Oncogene 37(36):5007\u20135019. https:\/\/doi.org\/10.1038\/S41388-018-0307-Z","journal-title":"Oncogene"},{"issue":"12","key":"9_CR85","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1016\/J.CMET.2023.11.001","volume":"35","author":"C Jiang","year":"2023","unstructured":"Jiang C, Liu J, He S, Xu W, Huang R, Pan W, Li X, Dai X, Guo J, Zhang T, Inuzuka H, Wang P, Asara JM, Xiao J, Wei W (2023) PRMT1 orchestrates with SAMTOR to govern mTORC1 methionine sensing via Arg-methylation of NPRL2. Cell Metab 35(12):2183\u20132199.e7. https:\/\/doi.org\/10.1016\/J.CMET.2023.11.001","journal-title":"Cell Metab"},{"key":"9_CR86","doi-asserted-by":"publisher","first-page":"104844","DOI":"10.1016\/j.phrs.2020.104844","volume":"158","author":"H Jiang","year":"2020","unstructured":"Jiang H, Zhang N, Tang T, Feng F, Sun H, Qu W (2020) Target the human alanine\/serine\/cysteine transporter 2(ASCT2): achievement and future for novel cancer therapy. Pharmacol Res 158:104844. https:\/\/doi.org\/10.1016\/j.phrs.2020.104844","journal-title":"Pharmacol Res"},{"issue":"2","key":"9_CR87","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41374-021-00666-7","volume":"102","author":"L Jin","year":"2022","unstructured":"Jin L, Kiang KMY, Cheng SY, Leung GKK (2022) Pharmacological inhibition of serine synthesis enhances temozolomide efficacy by decreasing O6-methylguanine DNA methyltransferase (MGMT) expression and reactive oxygen species (ROS)-mediated DNA damage in glioblastoma. Lab Invest 102(2):194\u2013203. https:\/\/doi.org\/10.1038\/s41374-021-00666-7","journal-title":"Lab Invest"},{"issue":"12","key":"9_CR88","doi-asserted-by":"publisher","first-page":"4055","DOI":"10.3390\/IJMS19124055","volume":"19","author":"FZ Kadayifci","year":"2018","unstructured":"Kadayifci FZ, Zheng S, Pan YX (2018) Molecular mechanisms underlying the link between diet and DNA methylation. Int J Mol Sci 19(12):4055. https:\/\/doi.org\/10.3390\/IJMS19124055","journal-title":"Int J Mol Sci"},{"issue":"4","key":"9_CR89","doi-asserted-by":"publisher","first-page":"568","DOI":"10.3390\/BIOM10040568","volume":"10","author":"P Kaiser","year":"2020","unstructured":"Kaiser P (2020) Methionine dependence of cancer. Biomolecules 10(4):568. https:\/\/doi.org\/10.3390\/BIOM10040568","journal-title":"Biomolecules"},{"issue":"12","key":"9_CR90","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1038\/s41588-022-01241-6","volume":"54","author":"S Kaluscha","year":"2022","unstructured":"Kaluscha S, Domcke S, Wirbelauer C, Stadler MB, Durdu S, Burger L, Sch\u00fcbeler D (2022) Evidence that direct inhibition of transcription factor binding is the prevailing mode of gene and repeat repression by DNA methylation. Nat Genet 54(12):1895\u20131906. https:\/\/doi.org\/10.1038\/s41588-022-01241-6","journal-title":"Nat Genet"},{"issue":"10","key":"9_CR91","doi-asserted-by":"publisher","first-page":"e3002371","DOI":"10.1371\/JOURNAL.PBIO.3002371","volume":"21","author":"A Karimian","year":"2023","unstructured":"Karimian A, Vogelauer M, Kurdistani SK (2023) Metabolic sinkholes: histones as methyl repositories. PLoS Biol 21(10):e3002371. https:\/\/doi.org\/10.1371\/JOURNAL.PBIO.3002371","journal-title":"PLoS Biol"},{"key":"9_CR92","doi-asserted-by":"publisher","unstructured":"Kavya Satheesh KS, Rani H, Jolly MK, Mahadevan V (2021) Epigenetics of epithelial to mesenchymal transition (EMT) in cancer. In: Epigenetics and metabolomics. Elsevier, Academic Press, United States. 237\u2013264. https:\/\/doi.org\/10.1016\/B978-0-323-85652-2.00001-4","DOI":"10.1016\/B978-0-323-85652-2.00001-4"},{"issue":"6","key":"9_CR93","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1158\/1078-0432.CCR-11-1909","volume":"18","author":"K Kawada","year":"2012","unstructured":"Kawada K, Nakamoto Y, Kawada M, Hida K, Matsumoto T, Murakami T, Hasegawa S, Togashi K, Sakai Y (2012) Relationship between 18F-fluorodeoxyglucose accumulation and KRAS \/ BRAF mutations in colorectal cancer. Clin Cancer Res 18(6):1696\u20131703. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-1909","journal-title":"Clin Cancer Res"},{"issue":"2","key":"9_CR94","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.bbcan.2016.04.001","volume":"1865","author":"A Kazanets","year":"2016","unstructured":"Kazanets A, Shorstova T, Hilmi K, Marques M, Witcher M (2016) Epigenetic silencing of tumor suppressor genes: paradigms, puzzles, and potential. Biochim Biophys Acta 1865(2):275\u2013288. https:\/\/doi.org\/10.1016\/j.bbcan.2016.04.001","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"9_CR95","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2007.02.005","volume":"128","author":"T Kouzarides","year":"2007","unstructured":"Kouzarides T (2007) Chromatin modifications and their function. Cell 128(4):693\u2013705. https:\/\/doi.org\/10.1016\/j.cell.2007.02.005","journal-title":"Cell"},{"issue":"3","key":"9_CR96","doi-asserted-by":"publisher","first-page":"e17706","DOI":"10.1371\/JOURNAL.PONE.0017706","volume":"6","author":"A Kulkarni","year":"2011","unstructured":"Kulkarni A, Dangat K, Kale A, Sable P, Chavan-Gautam P, Joshi S (2011) Effects of altered maternal folic acid, vitamin B12 and docosahexaenoic acid on placental global DNA methylation patterns in Wistar rats. PLoS One 6(3):e17706. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0017706","journal-title":"PLoS One"},{"issue":"1","key":"9_CR97","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.eururo.2021.03.005","volume":"80","author":"A Kumaraswamy","year":"2021","unstructured":"Kumaraswamy A, Welker Leng KR, Westbrook TC, Yates JA, Zhao SG, Evans CP, Feng FY, Morgan TM, Alumkal JJ (2021) Recent advances in epigenetic biomarkers and epigenetic targeting in prostate cancer. Eur Urol 80(1):71\u201381. https:\/\/doi.org\/10.1016\/j.eururo.2021.03.005","journal-title":"Eur Urol"},{"issue":"4","key":"9_CR98","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.celrep.2014.04.045","volume":"7","author":"CF Labuschagne","year":"2014","unstructured":"Labuschagne CF, van den Broek NJF, Mackay GM, Vousden KH, Maddocks ODK (2014) Serine, but not glycine, supports one-carbon metabolism and proliferation of cancer cells. Cell Rep 7(4):1248\u20131258. https:\/\/doi.org\/10.1016\/j.celrep.2014.04.045","journal-title":"Cell Rep"},{"issue":"6134","key":"9_CR99","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1126\/science.1232245","volume":"340","author":"PW Lewis","year":"2013","unstructured":"Lewis PW, M\u00fcller MM, Koletsky MS, Cordero F, Lin S, Banaszynski LA, Garcia BA, Muir TW, Becher OJ, Allis CD (2013) Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma. Science 340(6134):857\u2013861. https:\/\/doi.org\/10.1126\/science.1232245","journal-title":"Science"},{"issue":"25","key":"9_CR100","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1056\/NEJMoa1005143","volume":"363","author":"TJ Ley","year":"2010","unstructured":"Ley TJ, Ding L, Walter MJ, McLellan MD, Lamprecht T, Larson DE, Kandoth C, Payton JE, Baty J, Welch J, Harris CC, Lichti CF, Townsend RR, Fulton RS, Dooling DJ, Koboldt DC, Schmidt H, Zhang Q, Osborne JR et al (2010) DNMT3A mutations in acute myeloid leukemia. N Engl J Med 363(25):2424\u20132433. https:\/\/doi.org\/10.1056\/NEJMoa1005143","journal-title":"N Engl J Med"},{"issue":"1","key":"9_CR101","doi-asserted-by":"publisher","DOI":"10.1186\/S12943-024-02041-8","volume":"23","author":"Y Li","year":"2024","unstructured":"Li Y, Jin H, Li Q, Shi L, Mao Y, Zhao L (2024) The role of RNA methylation in tumor immunity and its potential in immunotherapy. Mol Cancer 23(1):130. https:\/\/doi.org\/10.1186\/S12943-024-02041-8","journal-title":"Mol Cancer"},{"issue":"26","key":"9_CR102","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.3748\/WJG.V25.I26.3392","volume":"25","author":"Y Liang","year":"2019","unstructured":"Liang Y, Zhang C, Dai DQ (2019) Identification of differentially expressed genes regulated by methylation in colon cancer based on bioinformatics analysis. World J Gastroenterol 25(26):3392\u20133407. https:\/\/doi.org\/10.3748\/WJG.V25.I26.3392","journal-title":"World J Gastroenterol"},{"issue":"510","key":"9_CR103","doi-asserted-by":"publisher","first-page":"eaao6604","DOI":"10.1126\/SCISIGNAL.AAO6604","volume":"10","author":"EC Lien","year":"2017","unstructured":"Lien EC, Ghisolfi L, Geck RC, Asara JM, Toker A (2017) Oncogenic PI3K promotes methionine dependency in breast cancer cells through the cystine-glutamate antiporter xCT. Sci Signal 10(510):eaao6604. https:\/\/doi.org\/10.1126\/SCISIGNAL.AAO6604","journal-title":"Sci Signal"},{"issue":"14","key":"9_CR104","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1177\/1535370216645211\/PDF","volume":"241","author":"B Liu","year":"2016","unstructured":"Liu B, Song J, Luan J, Sun X, Bai J, Wang H, Li A, Zhang L, Feng X, Du Z (2016) Promoter methylation status of tumor suppressor genes and inhibition of expression of DNA methyltransferase 1 in non-small cell lung cancer. Exp Biol Med 241(14):1531\u20131539. https:\/\/doi.org\/10.1177\/1535370216645211","journal-title":"Exp Biol Med"},{"issue":"1","key":"9_CR105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-024-46680-3","volume":"15","author":"GY Liu","year":"2024","unstructured":"Liu GY, Jouandin P, Bahng RE, Perrimon N, Sabatini DM (2024) An evolutionary mechanism to assimilate new nutrient sensors into the mTORC1 pathway. Nat Commun 15(1):1\u201316. https:\/\/doi.org\/10.1038\/s41467-024-46680-3","journal-title":"Nat Commun"},{"issue":"7","key":"9_CR106","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1016\/j.ymthe.2021.03.013","volume":"29","author":"N Liu","year":"2021","unstructured":"Liu N, Zhang JL, Yin M, Liu H, Zhang X, Li J, Yan B, Guo Y, Zhou J, Tao J, Hu S, Chen X, Peng C (2021) Inhibition of xCT suppresses the efficacy of anti-PD-1\/L1 melanoma treatment through exosomal PD-L1-induced macrophage M2 polarization. Mol Ther 29(7):2321\u20132334. https:\/\/pubmed.ncbi.nlm.nih.gov\/33744468\/","journal-title":"Mol Ther"},{"issue":"12","key":"9_CR107","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1007\/S00210-020-01858-6","volume":"393","author":"Y Liu","year":"2020","unstructured":"Liu Y, Bi T, Yuan F, Gao X, Jia G, Tian Z (2020) S-adenosylmethionine induces apoptosis and cycle arrest of gallbladder carcinoma cells by suppression of JAK2\/STAT3 pathways. Naunyn Schmiedeberg\u2019s Arch Pharmacol 393(12):2507\u20132515. https:\/\/doi.org\/10.1007\/S00210-020-01858-6","journal-title":"Naunyn Schmiedeberg\u2019s Arch Pharmacol"},{"issue":"1","key":"9_CR108","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ccell.2016.05.008","volume":"30","author":"R Lu","year":"2016","unstructured":"Lu R, Wang P, Parton T, Zhou Y, Chrysovergis K, Rockowitz S, Chen W-Y, Abdel-Wahab O, Wade PA, Zheng D, Wang GG (2016) Epigenetic perturbations by Arg882-mutated DNMT3A potentiate aberrant stem cell gene-expression program and acute leukemia development. Cancer Cell 30(1):92\u2013107. https:\/\/doi.org\/10.1016\/j.ccell.2016.05.008","journal-title":"Cancer Cell"},{"issue":"5","key":"9_CR109","doi-asserted-by":"publisher","first-page":"640","DOI":"10.3390\/PH18050640","volume":"18","author":"C Ma","year":"2025","unstructured":"Ma C, Xu A, Zuo L, Li Q, Fan F, Hu Y, Sun C (2025) Methionine dependency and restriction in cancer: exploring the pathogenic function and therapeutic potential.\u2002Pharmaceuticals\u200218(5):640.\u2002https:\/\/doi.org\/10.3390\/PH18050640","journal-title":"Pharmaceuticals"},{"issue":"2","key":"9_CR110","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1177\/1535370217740860","volume":"243","author":"LY Maldonado","year":"2018","unstructured":"Maldonado LY, Arsene D, Mato JM, Lu SC (2018) Methionine adenosyltransferases in cancers: mechanisms of dysregulation and implications for therapy. Exp Biol Med 243(2):107\u2013117. https:\/\/doi.org\/10.1177\/1535370217740860","journal-title":"Exp Biol Med"},{"issue":"4","key":"9_CR111","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.cell.2017.01.018","volume":"168","author":"N McGranahan","year":"2017","unstructured":"McGranahan N, Swanton C (2017) Clonal heterogeneity and tumor evolution: past, present, and the future. Cell\u2002168(4):613\u2013628.\u2002https:\/\/doi.org\/10.1016\/j.cell.2017.01.018","journal-title":"Cell"},{"key":"9_CR112","doi-asserted-by":"publisher","first-page":"100874","DOI":"10.1016\/j.neo.2022.100874","volume":"36","author":"A Mehdi","year":"2023","unstructured":"Mehdi A, Attias M, Arakelian A, Szyf M, Piccirillo CA, Rabbani SA (2023) S-adenosylmethionine blocks tumorigenesis and with immune checkpoint inhibitor enhances anti-cancer efficacy against BRAF mutant and wildtype melanomas. Neoplasia 36:100874. https:\/\/doi.org\/10.1016\/j.neo.2022.100874","journal-title":"Neoplasia"},{"issue":"7","key":"9_CR113","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/nm0795-686","volume":"1","author":"A Merlo","year":"1995","unstructured":"Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB, Sidransky D (1995) 5\u2019 CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16\/CDKN2\/MTS1 in human cancers. Nat Med 1(7):686\u2013692. https:\/\/doi.org\/10.1038\/nm0795-686","journal-title":"Nat Med"},{"issue":"7","key":"9_CR114","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41571-020-0357-3","volume":"17","author":"P Mittal","year":"2020","unstructured":"Mittal P, Roberts CWM (2020) The SWI\/SNF complex in cancer \u2014 biology, biomarkers and therapy. Nat Rev Clin Oncol 17(7):435\u2013448. https:\/\/doi.org\/10.1038\/s41571-020-0357-3","journal-title":"Nat Rev Clin Oncol"},{"key":"9_CR115","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.niox.2014.03.001","volume":"41","author":"K M\u00f3dis","year":"2014","unstructured":"M\u00f3dis K, Coletta C, Asimakopoulou A, Szczesny B, Chao C, Papapetropoulos A, Hellmich MR, Szabo C (2014) Effect of S-adenosyl-L-methionine (SAM), an allosteric activator of cystathionine-\u03b2-synthase (CBS) on colorectal cancer cell proliferation and bioenergetics in vitro. Nitric Oxide Biol Chem 41:146\u2013156. https:\/\/doi.org\/10.1016\/j.niox.2014.03.001","journal-title":"Nitric Oxide Biol Chem"},{"issue":"6","key":"9_CR116","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.molcel.2008.05.007","volume":"30","author":"F Mohn","year":"2008","unstructured":"Mohn F, Weber M, Rebhan M, Roloff TC, Richter J, Stadler MB, Bibel M, Sch\u00fcbeler D (2008) Lineage-specific polycomb targets and de novo DNA methylation define restriction and potential of neuronal progenitors. Mol Cell 30(6):755\u2013766. https:\/\/doi.org\/10.1016\/j.molcel.2008.05.007","journal-title":"Mol Cell"},{"issue":"23","key":"9_CR117","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1056\/NEJMOA2309169","volume":"389","author":"KN Moore","year":"2023","unstructured":"Moore KN, Angelergues A, Konecny GE, Garc\u00eda Y, Banerjee S, Lorusso D, Lee J-Y, Moroney JW, Colombo N, Roszak A, Tromp J, Myers T, Lee J-W, Beiner M, Cosgrove CM, Cibula D, Martin LP, Sabatier R, Buscema J et al (2023) Mirvetuximab soravtansine in FR\u03b1-positive, platinum-resistant ovarian cancer. N Engl J Med 389(23):2162\u20132174. https:\/\/doi.org\/10.1056\/NEJMOA2309169","journal-title":"N Engl J Med"},{"issue":"8","key":"9_CR118","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1158\/1541-7786.MCR-08-0040","volume":"6","author":"SR Morey Kinney","year":"2008","unstructured":"Morey Kinney SR, Smiraglia DJ, James SR, Moser MT, Foster BA, Karpf AR (2008) Stage-specific alterations of DNA methyltransferase expression, DNA hypermethylation, and DNA hypomethylation during prostate cancer progression in the transgenic adenocarcinoma of mouse prostate model. Mol Cancer Res 6(8):1365\u20131374.\u2002https:\/\/doi.org\/10.1158\/1541-7786.MCR-08-0040","journal-title":"Mol Cancer Res"},{"issue":"2","key":"9_CR119","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/ng.518","volume":"42","author":"RD Morin","year":"2010","unstructured":"Morin RD, Johnson NA, Severson TM, Mungall AJ, An J, Goya R, Paul JE, Boyle M, Woolcock BW, Kuchenbauer F, Yap D, Humphries RK, Griffith OL, Shah S, Zhu H, Kimbara M, Shashkin P, Charlot JF, Tcherpakov M et al (2010) Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nat Genet 42(2):181\u2013185. https:\/\/doi.org\/10.1038\/ng.518","journal-title":"Nat Genet"},{"issue":"11","key":"9_CR120","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1016\/S1470-2045(20)30441-1","volume":"21","author":"F Morschhauser","year":"2020","unstructured":"Morschhauser F, Tilly H, Chaidos A, McKay P, Phillips T, Assouline S, Batlevi CL, Campbell P, Ribrag V, Damaj GL, Dickinson M, Jurczak W, Kazmierczak M, Opat S, Radford J, Schmitt A, Yang J, Whalen J, Agarwal S et al (2020) Tazemetostat for patients with relapsed or refractory follicular lymphoma: an open-label, single-arm, multicentre, phase 2 trial. Lancet Oncol 21(11):1433\u20131442. https:\/\/doi.org\/10.1016\/S1470-2045(20)30441-1","journal-title":"Lancet Oncol"},{"key":"9_CR121","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1146\/ANNUREV.BIOCHEM.78.070907.103946","volume":"79","author":"N Mosammaparast","year":"2010","unstructured":"Mosammaparast N, Shi Y (2010) Reversal of histone methylation: biochemical and molecular mechanisms of histone demethylases. Annu Rev Biochem 79:155\u2013179.\u2002https:\/\/doi.org\/10.1146\/ANNUREV.BIOCHEM.78.070907.103946","journal-title":"Annu Rev Biochem"},{"issue":"7337","key":"9_CR122","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nature09727","volume":"471","author":"CG Mullighan","year":"2011","unstructured":"Mullighan CG, Zhang J, Kasper LH, Lerach S, Payne-Turner D, Phillips LA, Heatley SL, Holmfeldt L, Collins-Underwood JR, Ma J, Buetow KH, Pui C-H, Baker SD, Brindle PK, Downing JR (2011) CREBBP mutations in relapsed acute lymphoblastic leukaemia. Nature 471(7337):235\u2013239. https:\/\/doi.org\/10.1038\/nature09727","journal-title":"Nature"},{"issue":"31","key":"9_CR123","doi-asserted-by":"publisher","first-page":"4319","DOI":"10.3748\/WJG.V25.I31.4300","volume":"25","author":"B Murray","year":"2019","unstructured":"Murray B, Barbier-Torres L, Fan W, Mato JM, Lu SC (2019) Methionine adenosyltransferases in liver cancer. World J Gastroenterol 25(31):4319. https:\/\/doi.org\/10.3748\/WJG.V25.I31.4300","journal-title":"World J Gastroenterol"},{"issue":"7749","key":"9_CR124","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41586-019-1038-1","volume":"567","author":"BA Nacev","year":"2019","unstructured":"Nacev BA, Feng L, Bagert JD, Lemiesz AE, Gao J, Soshnev AA, Kundra R, Schultz N, Muir TW, Allis CD (2019a) The expanding landscape of \u2018oncohistone\u2019 mutations in human cancers. Nature 567(7749):473\u2013478. https:\/\/doi.org\/10.1038\/s41586-019-1038-1","journal-title":"Nature"},{"issue":"7749","key":"9_CR125","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41586-019-1038-1","volume":"567","author":"BA Nacev","year":"2019","unstructured":"Nacev BA, Feng L, Bagert JD, Lemiesz AE, Gao J, Soshnev AA, Kundra R, Schultz N, Muir TW, Allis CD (2019b) The expanding landscape of \u2018oncohistone\u2019 mutations in human cancers. Nature 567(7749):473\u2013478. https:\/\/doi.org\/10.1038\/s41586-019-1038-1","journal-title":"Nature"},{"issue":"6","key":"9_CR126","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.molcel.2019.08.030","volume":"76","author":"S Nagaraja","year":"2019","unstructured":"Nagaraja S, Quezada MA, Gillespie SM, Arzt M, Lennon JJ, Woo PJ, Hovestadt V, Kambhampati M, Filbin MG, Suva ML, Nazarian J, Monje M (2019) Histone variant and cell context determine H3K27M reprogramming of the enhancer landscape and oncogenic state. Mol Cell\u200276(6):965\u2013980.e12.\u2002https:\/\/doi.org\/10.1016\/j.molcel.2019.08.030","journal-title":"Mol Cell"},{"issue":"16","key":"9_CR127","first-page":"4346","volume":"60","author":"SJ Nass","year":"2000","unstructured":"Nass SJ, Herman JG, Gabrielson E, Iversen PW, Parl FF, Davidson NE, Graff JR (2000) Aberrant methylation of the estrogen receptor and E-cadherin 5\u2019 CpG islands increases with malignant progression in human breast cancer. Cancer Res 60(16):4346\u20134348","journal-title":"Cancer Res"},{"issue":"1","key":"9_CR128","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/J.GENE.2013.09.063","volume":"533","author":"FH Nazki","year":"2014","unstructured":"Nazki FH, Sameer AS, Ganaie BA (2014) Folate: metabolism, genes, polymorphisms and the associated diseases. Gene 533(1):11\u201320. https:\/\/doi.org\/10.1016\/J.GENE.2013.09.063","journal-title":"Gene"},{"issue":"16","key":"9_CR129","doi-asserted-by":"publisher","first-page":"5793","DOI":"10.1128\/MCB.22.16.5793-5800.2002","volume":"22","author":"MA Nikiforov","year":"2002","unstructured":"Nikiforov MA, Chandriani S, O\u2019Connell B, Petrenko O, Kotenko I, Beavis A, Sedivy JM, Cole MD (2002) A functional screen for Myc-responsive genes reveals serine hydroxymethyltransferase, a major source of the one-carbon unit for cell metabolism. Mol Cell Biol 22(16):5793\u20135800. https:\/\/doi.org\/10.1128\/MCB.22.16.5793-5800.2002","journal-title":"Mol Cell Biol"},{"key":"9_CR130","doi-asserted-by":"publisher","first-page":"144032","DOI":"10.1016\/j.gene.2019.144032","volume":"716","author":"R Nilsson","year":"2019","unstructured":"Nilsson R, Nicolaidou V, Koufaris C (2019) Mitochondrial MTHFD isozymes display distinct expression, regulation, and association with cancer.\u2002Gene\u2002716:144032.\u2002https:\/\/doi.org\/10.1016\/j.gene.2019.144032","journal-title":"Gene"},{"issue":"2","key":"9_CR131","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nm.2651","volume":"18","author":"P Ntziachristos","year":"2012","unstructured":"Ntziachristos P, Tsirigos A, Vlierberghe P Van, Nedjic J, Trimarchi T, Flaherty MS, Ferres-Marco D, da Ros V, Tang Z, Siegle J, Asp P, Hadler M, Rigo I, Keersmaecker K, De, Patel J, Huynh T, Utro F, Poglio S, Samon JB et al (2012) Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia. Nat Med 18(2):298\u2013302. https:\/\/doi.org\/10.1038\/nm.2651","journal-title":"Nat Med"},{"issue":"3","key":"9_CR132","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/890","volume":"19","author":"M Okano","year":"1998","unstructured":"Okano M, Xie S, Li E (1998) Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nat Genet 19(3):219\u2013220. https:\/\/doi.org\/10.1038\/890","journal-title":"Nat Genet"},{"issue":"11","key":"9_CR133","doi-asserted-by":"publisher","first-page":"e12891","DOI":"10.1111\/CPR.12891","volume":"53","author":"Y Ouyang","year":"2020","unstructured":"Ouyang Y, Wu Q, Li J, Sun S, Sun S (2020) S-adenosylmethionine: a metabolite critical to the regulation of autophagy. Cell Prolif 53(11):e12891. https:\/\/doi.org\/10.1111\/CPR.12891","journal-title":"Cell Prolif"},{"issue":"2","key":"9_CR134","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/ng.3757","volume":"49","author":"S Papillon-Cavanagh","year":"2017","unstructured":"Papillon-Cavanagh S, Lu C, Gayden T, Mikael LG, Bechet D, Karamboulas C, Ailles L, Karamchandani J, Marchione DM, Garcia BA, Weinreb I, Goldstein D, Lewis PW, Dancu OM, Dhaliwal S, Stecho W, Howlett CJ, Mymryk JS, Barrett JW et al (2017) Impaired H3K36 methylation defines a subset of head and neck squamous cell carcinomas. Nat Genet 49(2):180\u2013185. https:\/\/doi.org\/10.1038\/ng.3757","journal-title":"Nat. Genet"},{"issue":"3","key":"9_CR135","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/s41422-021-00606-6","volume":"32","author":"V Parreno","year":"2022","unstructured":"Parreno V, Martinez A-M, Cavalli G (2022) Mechanisms of polycomb group protein function in cancer. Cell Res 32(3):231\u2013253. https:\/\/doi.org\/10.1038\/s41422-021-00606-6","journal-title":"Cell Res"},{"issue":"6","key":"9_CR136","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3390\/MEDICINA55060296","volume":"55","author":"RM Pascale","year":"2019","unstructured":"Pascale RM, Peitta G, Simile MM, Feo F (2019) Alterations of methionine metabolism as potential targets for the prevention and therapy of hepatocellular carcinoma. Medicina 55(6):296. https:\/\/doi.org\/10.3390\/MEDICINA55060296","journal-title":"Medicina"},{"issue":"7337","key":"9_CR137","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/nature09730","volume":"471","author":"L Pasqualucci","year":"2011","unstructured":"Pasqualucci L, Dominguez-Sola D, Chiarenza A, Fabbri G, Grunn A, Trifonov V, Kasper LH, Lerach S, Tang H, Ma J, Rossi D, Chadburn A, Murty VV, Mullighan CG, Gaidano G, Rabadan R, Brindle PK, Dalla-Favera R (2011) Inactivating mutations of acetyltransferase genes in B-cell lymphoma. Nature 471(7337):189\u2013195. https:\/\/doi.org\/10.1038\/nature09730","journal-title":"Nature"},{"issue":"10","key":"9_CR138","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1038\/ng.2396","volume":"44","author":"M Peifer","year":"2012","unstructured":"Peifer M, Fern\u00e1ndez-Cuesta L, Sos ML, George J, Seidel D, Kasper LH, Plenker D, Leenders F, Sun R, Zander T, Menon R, Koker M, Dahmen I, M\u00fcller C, Di Cerbo V, Schildhaus H-U, Altm\u00fcller J, Baessmann I, Becker C et al (2012) Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Nat Genet 44(10):1104\u20131110. https:\/\/doi.org\/10.1038\/ng.2396","journal-title":"Nat Genet"},{"issue":"2","key":"9_CR139","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/s41375-021-01390-3","volume":"36","author":"AJ Pulikkottil","year":"2022","unstructured":"Pulikkottil AJ, Bamezai S, Ammer T, Mohr F, Feder K, Vegi NM, Mandal T, Kohlhofer U, Quintanilla-Martinez L, Sinha A, Buske C, Rawat VPS (2022) TET3 promotes AML growth and epigenetically regulates glucose metabolism and leukemic stem cell associated pathways. Leukemia 36(2):416\u2013425. https:\/\/doi.org\/10.1038\/s41375-021-01390-3","journal-title":"Leukemia"},{"issue":"11","key":"9_CR140","doi-asserted-by":"publisher","first-page":"104189","DOI":"10.1016\/j.drudis.2024.104189","volume":"29","author":"FE Pulous","year":"2024","unstructured":"Pulous FE, Steurer B, Pun FW, Zhang M, Ren F, Zhavoronkov A (2024) MAT2A inhibition combats metabolic and transcriptional reprogramming in cancer. Drug Discov Today 29(11):104189. https:\/\/doi.org\/10.1016\/j.drudis.2024.104189","journal-title":"Drug Discov Today"},{"issue":"1","key":"9_CR141","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/ajcn\/86.1.14","volume":"86","author":"V Purohit","year":"2007","unstructured":"Purohit V, Abdelmalek MF, Barve S, Benevenga NJ, Halsted CH, Kaplowitz N, Kharbanda KK, Liu QY, Lu SC, McClain CJ, Swanson C, Zakhari S (2007) Role of S-adenosylmethionine, folate, and betaine in the treatment of alcoholic liver disease: summary of a symposium. Am J Clin Nutr 86(1):14\u201324. https:\/\/doi.org\/10.1093\/ajcn\/86.1.14","journal-title":"Am J Clin Nutr"},{"issue":"10","key":"9_CR142","doi-asserted-by":"publisher","first-page":"5237","DOI":"10.1073\/pnas.97.10.5237","volume":"97","author":"BH Ramsahoye","year":"2000","unstructured":"Ramsahoye BH, Biniszkiewicz D, Lyko F, Clark V, Bird AP, Jaenisch R (2000) Non-CpG methylation is prevalent in embryonic stem cells and may be mediated by DNA methyltransferase 3a. Proc Natl Acad Sci 97(10):5237\u20135242. https:\/\/doi.org\/10.1073\/pnas.97.10.5237","journal-title":"Proc Natl Acad Sci"},{"issue":"5","key":"9_CR143","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.cell.2007.03.043","volume":"129","author":"A Raval","year":"2007","unstructured":"Raval A, Tanner SM, Byrd JC, Angerman EB, Perko JD, Chen S-S, Hackanson B, Grever MR, Lucas DM, Matkovic JJ, Lin TS, Kipps TJ, Murray F, Weisenburger D, Sanger W, Lynch J, Watson P, Jansen M, Yoshinaga Y et al (2007) Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia. Cell 129(5):879\u2013890. https:\/\/doi.org\/10.1016\/j.cell.2007.03.043","journal-title":"Cell"},{"issue":"11","key":"9_CR144","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1038\/NCB3629","volume":"19","author":"MA Reid","year":"2017","unstructured":"Reid MA, Dai Z, Locasale JW (2017) The impact of cellular metabolism on chromatin dynamics and epigenetics. Nat Cell Biol 19(11):1298\u20131306. https:\/\/doi.org\/10.1038\/NCB3629","journal-title":"Nat Cell Biol"},{"issue":"3","key":"9_CR145","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.ccell.2019.01.018","volume":"35","author":"M Reina-Campos","year":"2019","unstructured":"Reina-Campos M, Linares JF, Duran A, Cordes T, L\u2019Hermitte A, Badur MG, Bhangoo MS, Thorson PK, Richards A, Rooslid T, Garcia-Olmo DC, Nam-Cha SY, Salinas-Sanchez AS, Eng K, Beltran H, Scott DA, Metallo CM, Moscat J, Diaz-Meco MT (2019) Increased serine and one-carbon pathway metabolism by PKC\u03bb\/\u03b9 deficiency promotes neuroendocrine prostate cancer. Cancer Cell 35(3):385\u2013400.e9. https:\/\/doi.org\/10.1016\/j.ccell.2019.01.018","journal-title":"Cancer Cell"},{"issue":"12","key":"9_CR146","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1158\/0008-5472.CAN-11-3546","volume":"72","author":"G Ren","year":"2012","unstructured":"Ren G, Baritaki S, Marathe H, Feng J, Park S, Beach S, Bazeley PS, Beshir AB, Fenteany G, Mehra R, Daignault S, Al-Mulla F, Keller E, Bonavida B, de la Serna I, Yeung KC (2012) Polycomb protein EZH2 regulates tumor invasion via the transcriptional repression of the metastasis suppressor RKIP in breast and prostate cancer. Cancer Res 72(12):3091\u20133104. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-3546","journal-title":"Cancer Res"},{"issue":"3","key":"9_CR147","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.molcel.2014.06.005","volume":"55","author":"EM Riising","year":"2014","unstructured":"Riising EM, Comet I, Leblanc B, Wu X, Johansen JV, Helin K (2014) Gene silencing triggers polycomb repressive complex 2 recruitment to CpG islands genome wide. Mol Cell 55(3):347\u2013360. https:\/\/doi.org\/10.1016\/j.molcel.2014.06.005","journal-title":"Mol Cell"},{"issue":"5","key":"9_CR148","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/ng1773","volume":"38","author":"S Ropero","year":"2006","unstructured":"Ropero S, Fraga MF, Ballestar E, Hamelin R, Yamamoto H, Boix-Chornet M, Caballero R, Alaminos M, Setien F, Paz MF, Herranz M, Palacios J, Arango D, Orntoft TF, Aaltonen LA, Schwartz S, Esteller M (2006) A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition. Nat Genet 38(5):566\u2013569. https:\/\/doi.org\/10.1038\/ng1773","journal-title":"Nat Genet"},{"issue":"2","key":"9_CR149","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nrm.2016.140","volume":"18","author":"BR Sabari","year":"2017","unstructured":"Sabari BR, Zhang D, Allis CD, Zhao Y (2017) Metabolic regulation of gene expression through histone acylations. Nat Rev Mol Cell Biol 18(2):90\u2013101. https:\/\/doi.org\/10.1038\/nrm.2016.140","journal-title":"Nat Rev Mol Cell Biol"},{"key":"9_CR150","doi-asserted-by":"publisher","first-page":"101821","DOI":"10.1016\/j.tranon.2023.101821","volume":"39","author":"HQ Sadida","year":"2024","unstructured":"Sadida HQ, Abdulla A, Marzooqi S, Al, Hashem S, Macha MA, Akil ASAS, Bhat AA (2024) Epigenetic modifications: key players in cancer heterogeneity and drug resistance. Transl Oncol 39:101821. https:\/\/doi.org\/10.1016\/j.tranon.2023.101821","journal-title":"Transl Oncol"},{"issue":"6","key":"9_CR151","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/s41588-022-01091-2","volume":"54","author":"A Sankar","year":"2022","unstructured":"Sankar A, Mohammad F, Sundaramurthy AK, Wang H, Lerdrup M, Tatar T, Helin K (2022) Histone editing elucidates the functional roles of H3K27 methylation and acetylation in mammals. Nat Genet 54(6):754\u2013760. https:\/\/doi.org\/10.1038\/s41588-022-01091-2","journal-title":"Nat Genet"},{"issue":"23","key":"9_CR152","doi-asserted-by":"publisher","first-page":"3617","DOI":"10.1016\/J.FEBSLET.2015.10.011","volume":"589","author":"M Scalise","year":"2015","unstructured":"Scalise M, Pochini L, Pingitore P, Hedfalk K, Indiveri C (2015) Cysteine is not a substrate but a specific modulator of human ASCT2 (SLC1A5) transporter. FEBS Lett 589(23):3617\u20133623. https:\/\/doi.org\/10.1016\/J.FEBSLET.2015.10.011","journal-title":"FEBS Lett"},{"issue":"5","key":"9_CR153","first-page":"2276","volume":"12","author":"JC Sedillo","year":"2022","unstructured":"Sedillo JC, Cryns VL (2022) Targeting the methionine addiction of cancer. Am J Cancer Res 12(5):2276. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9185618\/","journal-title":"Am J Cancer Res"},{"issue":"12","key":"9_CR154","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.1016\/j.celrep.2017.11.092","volume":"21","author":"H Shima","year":"2017","unstructured":"Shima H, Matsumoto M, Ishigami Y, Ebina M, Muto A, Sato Y, Kumagai S, Ochiai K, Suzuki T, Igarashi K (2017) S-adenosylmethionine synthesis is regulated by selective N6-adenosine methylation and mRNA degradation involving METTL16 and YTHDC1. Cell Rep\u200221(12):3354\u20133363.\u2002https:\/\/doi.org\/10.1016\/j.celrep.2017.11.092","journal-title":"Cell Rep"},{"key":"9_CR155","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.gene.2017.11.014","volume":"642","author":"Z Song","year":"2018","unstructured":"Song Z, Feng C, Lu Y, Lin Y, Dong C (2018) PHGDH is an independent prognosis marker and contributes cell proliferation, migration and invasion in human pancreatic cancer. Gene 642:43\u201350. https:\/\/doi.org\/10.1016\/j.gene.2017.11.014","journal-title":"Gene"},{"issue":"6","key":"9_CR156","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/nm.4092","volume":"22","author":"GP Souroullas","year":"2016","unstructured":"Souroullas GP, Jeck WR, Parker JS, Simon JM, Liu J-Y, Paulk J, Xiong J, Clark KS, Fedoriw Y, Qi J, Burd CE, Bradner JE, Sharpless NE (2016) An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation. Nat Med 22(6):632\u2013640. https:\/\/doi.org\/10.1038\/nm.4092","journal-title":"Nat Med"},{"issue":"12","key":"9_CR157","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/NCB3264","volume":"17","author":"H Sperber","year":"2015","unstructured":"Sperber H, Mathieu J, Wang Y, Ferreccio A, Hesson J, Xu Z, Fischer KA, Devi A, Detraux D, Gu H, Battle SL, Showalter M, Valensisi C, Bielas JH, Ericson NG, Margaretha L, Robitaille AM, Margineantu D, Fiehn O et al (2015) The metabolome regulates the epigenetic landscape during naive-to-primed human embryonic stem cell transition. Nat Cell Biol\u200217(12):1523\u20131535.\u2002https:\/\/doi.org\/10.1038\/NCB3264","journal-title":"Nat Cell Biol"},{"issue":"5","key":"9_CR158","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1042\/EBC20200009","volume":"64","author":"A Sriraman","year":"2020","unstructured":"Sriraman A, Debnath TK, Xhemalce B, Miller KM (2020) Making it or breaking it: DNA methylation and genome integrity. Essays Biochem 64(5):687\u2013703. https:\/\/doi.org\/10.1042\/EBC20200009","journal-title":"Essays Biochem"},{"key":"9_CR159","doi-asserted-by":"publisher","unstructured":"Stankovi\u0107 A (2020) Global DNA methylation as a potential underlying mechanism of congenital disease development. In: DNA methylation mechanism. IntechOpen, Limited, United Kingdom pp 1\u201321. https:\/\/doi.org\/10.5772\/INTECHOPEN.90996","DOI":"10.5772\/INTECHOPEN.90996"},{"issue":"4","key":"9_CR160","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/cr.2015.33","volume":"25","author":"L Sun","year":"2015","unstructured":"Sun L, Song L, Wan Q, Wu G, Li X, Wang Y, Wang J, Liu Z, Zhong X, He X, Shen S, Pan X, Li A, Wang Y, Gao P, Tang H, Zhang H (2015a) cMyc-mediated activation of serine biosynthesis pathway is critical for cancer progression under nutrient deprivation conditions. Cell Res 25(4):429\u2013444. https:\/\/doi.org\/10.1038\/cr.2015.33","journal-title":"Cell Res"},{"issue":"6127","key":"9_CR162","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1126\/science.1230184","volume":"339","author":"ML Suv\u00e0","year":"2013","unstructured":"Suv\u00e0 ML, Riggi N, Bernstein BE (2013) Epigenetic reprogramming in cancer. Science 339(6127):1567\u20131570. https:\/\/doi.org\/10.1126\/science.1230184","journal-title":"Science"},{"issue":"1","key":"9_CR163","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1002\/MOG2.59","volume":"3","author":"L Tao","year":"2024","unstructured":"Tao L, Zhou Y, Luo Y, Qiu J, Xiao Y, Zou J, Zhang Y, Liu X, Yang X, Gou K, Xu J, Guan X, Cen X, Zhao Y (2024) Epigenetic regulation in cancer therapy: from mechanisms to clinical advances. MedComm Oncol 3(1):e59. https:\/\/doi.org\/10.1002\/MOG2.59","journal-title":"MedComm Oncol"},{"issue":"4","key":"9_CR164","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/S00280-020-04218-6","volume":"87","author":"E Teixeira","year":"2021","unstructured":"Teixeira E, Silva C, Martel F (2021) The role of the glutamine transporter ASCT2 in antineoplastic therapy. Cancer Chemother Pharmacol 87(4):447\u2013464. https:\/\/doi.org\/10.1007\/S00280-020-04218-6","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"9_CR165","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01762-6","volume":"22","author":"E Thieme","year":"2023","unstructured":"Thieme E, Bruss N, Sun D, Dominguez EC, Coleman D, Liu T, Roleder C, Martinez M, Garcia-Mansfield K, Ball B, Pirrotte P, Wang L, Xia Z, Danilov AV (2023) CDK9 inhibition induces epigenetic reprogramming revealing strategies to circumvent resistance in lymphoma. Mol Cancer 22(1):64. https:\/\/doi.org\/10.1186\/s12943-023-01762-6","journal-title":"Mol Cancer"},{"issue":"4","key":"9_CR166","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.ccr.2013.08.020","volume":"24","author":"LA Timmerman","year":"2013","unstructured":"Timmerman LA, Holton T, Yuneva M, Louie RJ, Padr\u00f3 M, Daemen A, Hu M, Chan DA, Ethier SP, van\u2019tVeer LJ, Polyak K, McCormick F, Gray JW (2013) Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic target. Cancer Cell 24(4):450\u2013465. https:\/\/doi.org\/10.1016\/j.ccr.2013.08.020","journal-title":"Cancer Cell"},{"issue":"8","key":"9_CR167","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-014-0061-y","volume":"6","author":"W Timp","year":"2014","unstructured":"Timp W, Bravo HC, McDonald OG, Goggins M, Umbricht C, Zeiger M, Feinberg AP, Irizarry RA (2014) Large hypomethylated blocks as a universal defining epigenetic alteration in human solid tumors. Genome Med 6(8):61. https:\/\/doi.org\/10.1186\/s13073-014-0061-y","journal-title":"Genome Med"},{"issue":"6","key":"9_CR168","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.ccr.2013.04.020","volume":"23","author":"N Tiwari","year":"2013","unstructured":"Tiwari N, Tiwari VK, Waldmeier L, Balwierz PJ, Arnold P, Pachkov M, Meyer-Schaller N, Sch\u00fcbeler D, van\u00a0Nimwegen E, Christofori G (2013) Sox4 is a master regulator of epithelial-mesenchymal transition by controlling Ezh2 expression and epigenetic reprogramming. Cancer Cell 23(6):768\u2013783. https:\/\/doi.org\/10.1016\/j.ccr.2013.04.020","journal-title":"Cancer Cell"},{"issue":"1","key":"9_CR169","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3390\/HEALTHCARE10010061","volume":"10","author":"JA Vaccaro","year":"2022","unstructured":"Vaccaro JA, Naser SA (2022) The role of methyl donors of the methionine cycle in gastrointestinal infection and inflammation. Healthcare 10(1):61. https:\/\/doi.org\/10.3390\/HEALTHCARE10010061","journal-title":"Healthcare"},{"issue":"1","key":"9_CR170","doi-asserted-by":"publisher","DOI":"10.1038\/srep17911","volume":"5","author":"AR Vandiver","year":"2015","unstructured":"Vandiver AR, Idrizi A, Rizzardi L, Feinberg AP, Hansen KD (2015) DNA methylation is stable during replication and cell cycle arrest. Sci Rep 5(1):17911. https:\/\/doi.org\/10.1038\/srep17911","journal-title":"Sci Rep"},{"issue":"1","key":"9_CR171","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1093\/ije\/dyr184","volume":"41","author":"CH Waddington","year":"2012","unstructured":"Waddington CH (2012) The epigenotype. Int J Epidemiol 41(1):10\u201313. https:\/\/doi.org\/10.1093\/ije\/dyr184","journal-title":"Int J Epidemiol"},{"issue":"10","key":"9_CR172","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/S41419-024-07093-8","volume":"15","author":"X Wan","year":"2024","unstructured":"Wan X, Zeng W, Fan H, Wang C, Han S, Sun Z, Tang M, Shao J, Liu Y, Fang Y, Jia J, Tang Y, Zhang Y, Zhao B, Fang D (2024) MAT2B regulates the protein level of MAT2A to preserve RNA N6-methyladenosine. Cell Death Dis 15(10):714. https:\/\/doi.org\/10.1038\/S41419-024-07093-8","journal-title":"Cell Death Dis"},{"issue":"5","key":"9_CR173","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1093\/advances\/nmac055","volume":"13","author":"G Wang","year":"2022","unstructured":"Wang G, Chen L, Qin S, Zhang T, Yao J, Yi Y, Deng L (2022) Mechanistic target of rapamycin complex 1: from a nutrient sensor to a key regulator of metabolism and health. Adv Nutr 13(5):1882\u20131900. https:\/\/doi.org\/10.1093\/advances\/nmac055","journal-title":"Adv Nutr"},{"issue":"1","key":"9_CR174","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ccr.2013.12.007","volume":"25","author":"L Wang","year":"2014","unstructured":"Wang L, Zhao Z, Meyer MB, Saha S, Yu M, Guo A, Wisinski KB, Huang W, Cai W, Pike JW, Yuan M, Ahlquist P, Xu W (2014) CARM1 methylates chromatin remodeling factor BAF155 to enhance tumor progression and metastasis. Cancer Cell 25(1):21\u201336. https:\/\/doi.org\/10.1016\/j.ccr.2013.12.007","journal-title":"Cancer Cell"},{"key":"9_CR175","doi-asserted-by":"publisher","first-page":"217117","DOI":"10.1016\/j.canlet.2024.217117","volume":"598","author":"X Wang","year":"2024","unstructured":"Wang X, Liu X, Xiao R, Fang Y, Zhou F, Gu M, Luo X, Jiang D, Tang Y, You L, Zhao Y (2024) Histone lactylation dynamics: unlocking the triad of metabolism, epigenetics, and immune regulation in metastatic cascade of pancreatic cancer. Cancer Lett 598:217117. https:\/\/doi.org\/10.1016\/j.canlet.2024.217117","journal-title":"Cancer Lett"},{"issue":"50","key":"9_CR176","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1007\/BF01504608","volume":"12","author":"O Warburg","year":"1924","unstructured":"Warburg O (1924) ber den Stoffwechsel der Carcinomzelle. Naturwissenschaften 12(50):1131\u20131137. https:\/\/doi.org\/10.1007\/BF01504608","journal-title":"Naturwissenschaften"},{"issue":"5930","key":"9_CR177","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1126\/science.1164097","volume":"324","author":"KE Wellen","year":"2009","unstructured":"Wellen KE, Hatzivassiliou G, Sachdeva UM, Bui TV, Cross JR, Thompson CB (2009) ATP-citrate lyase links cellular metabolism to histone acetylation. Science 324(5930):1076\u20131080. https:\/\/doi.org\/10.1126\/science.1164097","journal-title":"Science"},{"issue":"19","key":"9_CR178","doi-asserted-by":"publisher","first-page":"13548","DOI":"10.1074\/jbc.M510023200","volume":"281","author":"AJ Wilson","year":"2006","unstructured":"Wilson AJ, Byun D-S, Popova N, Murray LB, L\u2019Italien K, Sowa Y, Arango D, Velcich A, Augenlicht LH, Mariadason JM (2006) Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer. J Biol Chem 281(19):13548\u201313558. https:\/\/doi.org\/10.1074\/jbc.M510023200","journal-title":"J Biol Chem"},{"issue":"2","key":"9_CR179","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/0006-291X(87)91048-5","volume":"145","author":"DM Woodcock","year":"1987","unstructured":"Woodcock DM, Crowther PJ, Diver WP (1987) The majority of methylated deoxycytidines in human DNA are not in the CpG dinucleotide. Biochem Biophys Res Commun 145(2):888\u2013894. https:\/\/doi.org\/10.1016\/0006-291X(87)91048-5","journal-title":"Biochem Biophys Res Commun"},{"key":"9_CR180","doi-asserted-by":"publisher","first-page":"5553","DOI":"10.2147\/OTT.S105787","volume":"9","author":"Y Xian","year":"2016","unstructured":"Xian Y, Zhang S, Wang X, Qin J, Wang W, Wu H (2016) Phosphoglycerate dehydrogenase is a novel predictor for poor prognosis in gastric cancer. Onco Targets Ther 9:5553\u20135560. https:\/\/doi.org\/10.2147\/OTT.S105787","journal-title":"Onco Targets Ther"},{"issue":"8002","key":"9_CR181","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41586-024-07103-x","volume":"627","author":"M Yamagishi","year":"2024","unstructured":"Yamagishi M, Kuze Y, Kobayashi S, Nakashima M, Morishima S, Kawamata T, Makiyama J, Suzuki K, Seki M, Abe K, Imamura K, Watanabe E, Tsuchiya K, Yasumatsu I, Takayama G, Hizukuri Y, Ito K, Taira Y, Nannya Y et al (2024) Mechanisms of action and resistance in histone methylation-targeted therapy. Nature 627(8002):221\u2013228. https:\/\/doi.org\/10.1038\/s41586-024-07103-x","journal-title":"Nature"},{"key":"9_CR182","doi-asserted-by":"publisher","unstructured":"Yang G, Shan D, Zhao R, Li G (2022) Metabolism-associated DNA methylation signature stratifies lower-grade glioma patients and predicts response to immunotherapy. Front Cell Dev Biol 10:902298. https:\/\/doi.org\/10.3389\/fcell.2022.902298","DOI":"10.3389\/fcell.2022.902298"},{"issue":"2","key":"9_CR183","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1042\/BJ20101754","volume":"436","author":"H Yang","year":"2011","unstructured":"Yang H, Li TWH, Peng J, Mato JM, Lu SC (2011) Insulin-like growth factor 1 activates methionine adenosyltransferase 2A transcription by multiple pathways in human colon cancer cells. Biochem J 436(2):507\u2013516. https:\/\/doi.org\/10.1042\/BJ20101754","journal-title":"Biochem J"},{"issue":"1","key":"9_CR184","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nrc3409","volume":"13","author":"Y Yang","year":"2013","unstructured":"Yang Y, Bedford MT (2013) Protein arginine methyltransferases and cancer. Nat Rev Cancer 13(1):37\u201350. https:\/\/doi.org\/10.1038\/nrc3409","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"9_CR185","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1182\/blood-2010-11-321208","volume":"117","author":"DB Yap","year":"2011","unstructured":"Yap DB, Chu J, Berg T, Schapira M, Cheng S-WG, Moradian A, Morin RD, Mungall AJ, Meissner B, Boyle M, Marquez VE, Marra MA, Gascoyne RD, Humphries RK, Arrowsmith CH, Morin GB, Aparicio SAJR (2011) Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation. Blood 117(8):2451\u20132459. https:\/\/doi.org\/10.1182\/blood-2010-11-321208","journal-title":"Blood"},{"issue":"6","key":"9_CR186","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1158\/0008-5472.CAN-03-3972","volume":"64","author":"S Yegnasubramanian","year":"2004","unstructured":"Yegnasubramanian S, Kowalski J, Gonzalgo ML, Zahurak M, Piantadosi S, Walsh PC, Bova GS, De Marzo AM, Isaacs WB, Nelson WG (2004) Hypermethylation of CpG islands in primary and metastatic human prostate cancer. Cancer Res 64(6):1975\u20131986. https:\/\/doi.org\/10.1158\/0008-5472.CAN-03-3972","journal-title":"Cancer Res"},{"issue":"11","key":"9_CR187","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/s41419-019-2062-7","volume":"10","author":"W Yu","year":"2019","unstructured":"Yu W, Huang W, Yang Y, Qiu R, Zeng Y, Hou Y, Sun G, Shi H, Leng S, Feng D, Chen Y, Wang S, Teng X, Yu H, Wang Y (2019) GATA3 recruits UTX for gene transcriptional activation to suppress metastasis of breast cancer. Cell Death Dis 10(11):832. https:\/\/doi.org\/10.1038\/s41419-019-2062-7","journal-title":"Cell Death Dis"},{"issue":"10","key":"9_CR188","doi-asserted-by":"publisher","first-page":"e705","DOI":"10.1002\/MCO2.705","volume":"5","author":"Z Yu","year":"2024","unstructured":"Yu Z, Kuang Y, Xue L, Ma X, Li T, Yuan L, Li M, Xue G, Li Z, Tang F, Tang J, Shan J, Wang W, Tang R, Zhou F (2024) SCR-7952, a highly selective MAT2A inhibitor, demonstrates synergistic antitumor activities in combination with the S-adenosylmethionine-competitive or the methylthioadenosine-cooperative protein arginine methyltransferase 5 inhibitors in methylthioadenosine phosphorylase-deleted tumors. MedComm 5(10):e705. https:\/\/doi.org\/10.1002\/MCO2.705","journal-title":"MedComm"},{"issue":"14","key":"9_CR189","doi-asserted-by":"publisher","first-page":"11621","DOI":"10.1074\/jbc.C200045200","volume":"277","author":"P Zegerman","year":"2002","unstructured":"Zegerman P, Canas B, Pappin D, Kouzarides T (2002) Histone H3 lysine 4 methylation disrupts binding of nucleosome remodeling and deacetylase (NuRD) repressor complex. J Biol Chem 277(14):11621\u201311624. https:\/\/doi.org\/10.1074\/jbc.C200045200","journal-title":"J Biol Chem"},{"key":"9_CR190","doi-asserted-by":"publisher","first-page":"104352","DOI":"10.1016\/j.phrs.2019.104352","volume":"149","author":"Jdeng Zeng","year":"2019","unstructured":"Zeng, J. deng, Wu, W. K. K., Wang, H. yun, & Li, X. xing (2019) Serine and one-carbon metabolism, a bridge that links mTOR signaling and DNA methylation in cancer. Pharmacol Res 149:104352. https:\/\/doi.org\/10.1016\/j.phrs.2019.104352","journal-title":"Pharmacol Res"},{"issue":"11","key":"9_CR191","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1016\/j.celrep.2017.05.067","volume":"19","author":"B Zhang","year":"2017","unstructured":"Zhang B, Zheng A, Hydbring P, Ambroise G, Ouchida AT, Goiny M, Vakifahmetoglu-Norberg H, Norberg E (2017) PHGDH defines a metabolic subtype in lung adenocarcinomas with poor prognosis. Cell Rep\u200219(11):2289\u20132303.\u2002https:\/\/doi.org\/10.1016\/j.celrep.2017.05.067","journal-title":"Cell Rep"},{"issue":"7779","key":"9_CR192","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang D, Tang Z, Huang H, Zhou G, Cui C, Weng Y, Liu W, Kim S, Lee S, Perez-Neut M, Ding J, Czyz D, Hu R, Ye Z, He M, Zheng YG, Shuman HA, Dai L, Ren B et al (2019) Metabolic regulation of gene expression by histone lactylation. Nature 574(7779):575\u2013580. https:\/\/doi.org\/10.1038\/s41586-019-1678-1","journal-title":"Nature"},{"key":"9_CR193","doi-asserted-by":"publisher","first-page":"1184626","DOI":"10.3389\/FONC.2023.1184626","volume":"13","author":"J Zhang","year":"2023","unstructured":"Zhang J, Bai J, Gong C, Wang J, Cheng Y, Zhao J, Xiong H (2023) Serine-associated one-carbon metabolic reprogramming: a new anti-cancer therapeutic strategy. Front Oncol 13:1184626. https:\/\/doi.org\/10.3389\/FONC.2023.1184626","journal-title":"Front Oncol"},{"issue":"1","key":"9_CR194","doi-asserted-by":"publisher","DOI":"10.1038\/S41467-025-59119-0","volume":"16","author":"L Zhang","year":"2025","unstructured":"Zhang L, Zhao X, Hu J, Li T, Chen H-Z, Zhang A, Wang H, Yu J, Zhang L (2025) PRPS2 enhances RNA m6A methylation by stimulating SAM synthesis through enzyme-dependent and independent mechanisms. Nat Commun 16(1):3966. https:\/\/doi.org\/10.1038\/S41467-025-59119-0","journal-title":"Nat Commun"},{"issue":"1","key":"9_CR195","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-017-0081-z","volume":"5","author":"W Zhang","year":"2017","unstructured":"Zhang W, Xu J (2017) DNA methyltransferases and their roles in tumorigenesis. Biomark Res 5(1):1. https:\/\/doi.org\/10.1186\/s40364-017-0081-z","journal-title":"Biomark Res"},{"issue":"10","key":"9_CR196","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.18632\/AGING.101584","volume":"10","author":"X Zhang","year":"2018","unstructured":"Zhang X, Tang J, Shen N, Ren K (2018) A single-nucleotide polymorphism (rs1805087) in the methionine synthase (METH) gene increases the risk of prostate cancer. Aging 10(10):2741\u20132754. https:\/\/doi.org\/10.18632\/AGING.101584","journal-title":"Aging"},{"issue":"2","key":"9_CR197","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.molcel.2016.12.013","volume":"65","author":"YW Zhang","year":"2017","unstructured":"Zhang YW, Wang Z, Xie W, Cai Y, Xia L, Easwaran H, Luo J, Yen R-WC, Li Y, Baylin SB (2017) Acetylation enhances TET2 function in protecting against abnormal DNA methylation during oxidative stress. Mol Cell 65(2):323\u2013335. https:\/\/doi.org\/10.1016\/j.molcel.2016.12.013","journal-title":"Mol Cell"},{"issue":"5","key":"9_CR198","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S1535-6108(04)00114-X","volume":"5","author":"P Zhu","year":"2004","unstructured":"Zhu P, Martin E, Mengwasser J, Schlag P, Janssen K-P, G\u00f6ttlicher M (2004) Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis. Cancer Cell 5(5):455\u2013463. https:\/\/doi.org\/10.1016\/S1535-6108(04)00114-X","journal-title":"Cancer Cell"},{"issue":"1","key":"9_CR199","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7051","volume":"6","author":"D Zingg","year":"2015","unstructured":"Zingg D, Debbache J, Schaefer SM, Tuncer E, Frommel SC, Cheng P, Arenas-Ramirez N, Haeusel J, Zhang Y, Bonalli M, McCabe MT, Creasy CL, Levesque MP, Boyman O, Santoro R, Shakhova O, Dummer R, Sommer L (2015) The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors. Nat Commun 6(1):6051. https:\/\/doi.org\/10.1038\/ncomms7051","journal-title":"Nat Commun"}],"container-title":["Advances in Experimental Medicine and Biology","Cancer Metabolic Remodeling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-032-12166-0_9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T11:17:37Z","timestamp":1783768657000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-032-12166-0_9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9783032121653","9783032121660"],"references-count":198,"URL":"https:\/\/doi.org\/10.1007\/978-3-032-12166-0_9","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"12 July 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}